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Abstract
The present systematic literature review is part of the 5th revision of the Nordic Nutrition Recommendations.
The overall aim was to review recent scientific data valid in a Nordic setting on the short- and long-term
health effects of breastfeeding (duration of both any and exclusive breastfeeding) and introduction of foods
other than breast milk. The initial literature search resulted in 2,011 abstracts; 416 identified as potentially
relevant. Full paper review resulted in 60 quality assessed papers (6A, 48B, and 6C). A complementary search
found some additional papers. The grade of evidence was classified as convincing, probable, limited-
suggestive, and limited-no conclusion. The evidence was convincing of a protective dose/duration effect of
breastfeeding against overweight and obesity in childhood and adolescence, overall infections, acute otitis
media, and gastrointestinal and respiratory tract infections. The evidence was probable that exclusive
breastfeeding for longer than 4 months is associated with slower weight gain during the second half of the first
year which could be part of the reason behind the reduced risk of later overweight or obesity. There was also
probable evidence that breastfeeding is a protective factor against inflammatory bowel disease, celiac disease,
and diabetes (type 1 and 2), provides beneficial effects on IQ and developmental scores of children as well as a
small reductive effect on blood pressure and blood cholesterol levels in adulthood. Other associations
explored were limited-suggestive or inconclusive. In conclusion, convincing and probable evidence was found
for benefits of breastfeeding on several outcomes. The recommendation in NNR2004 about exclusive
breastfeeding for 6 months and continued partial breastfeeding thereafter can stand unchanged. The
relatively low proportion of infants in the Nordic countries following this recommendation indicates that
strategies that protect, support and promote breastfeeding should be enhanced, and should also recognize the
benefits for long-term health.
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Background
The World Health Organization (WHO) recommends
exclusive breastfeeding during the first six months of life
(13). From six months onwards, continued breastfeeding
combined with complementary foods of good quality in
sufficient quantities for 2 years or longer is recom-
mended. Exclusive breastfeeding means that the child
only receives breast milk, and if necessary the addition of
vitamins, minerals, and medicine. The WHO recommen-
dation applies to all countries and populations regardless
of economic status or developmental level.
All the Nordic countries have relatively high breast-
feeding rates. After birth, virtually all mothers breastfeed
their infants and between 58 and 80% of the infants are
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still breastfed at 6 months (Table 1). The rate of exclusive
breastfeeding is also high in the first months, but
decreases quickly to between 23 and 60% of infants
exclusively breastfed at 4 months. The majority are
introduced to other foods before 6 months of age.
Breastfeeding has many health benefits for both baby
and mother. Breast milk is not only a food source but
contains immune-related components and various bio-
logically active substances that contribute to efficient
nutrient utilization and gives the child active and passive
protection against infections (11). Breastfeeding also pro-
vides numerous short- and long-term health benefits. In
developing countries, breastfeeding can be the difference
between life and death for several reasons including
poor hygiene and lack of clean water. The impact of
breastfeeding on mortality rates among healthy full-
term infants in developed countries is unclear due to a
scarcity of studies focused on this matter. However, there is
clear evidence that the child’s morbidity is affected,
notably with the increased risk of gastroenteritis and
acute otitis media. For other diseases the level of evi-
dence is weaker and variable. However, in a Nordic setting
infant formula is a safe option if breastfeeding is not
possible.
In 2010, the Nordic Council of Ministers launched a
project aimed at reviewing the scientific basis of the
NNR issued in 2004 (12) and as necessary, to update the
guidelines for the 5th edition. The NNR5 project is mainly
focused on revising the areas in which new scientific
knowledge, with special relevance to the Nordic setting,
has emerged since the 4th edition. A number of systematic
literature reviews (SLRs) will form the basis for the
update.
The present SLR is focused on breastfeeding and
introduction of solid food and the association with
several different health outcomes.
Aims
The overall aim was to review recent scientific data
valid in a Nordic setting on the short- and long-term
health effects of breastfeeding (duration of both any and
exclusive breastfeeding) and introduction of foods other
than breast milk in order to assess the validity of the
current Nordic recommendations. A second aim was to
provide a background for the planned update on the
chapter on breastfeeding.
Research/key questions
1. What are the associations between duration of exclu-
sive breastfeeding/any breastfeeding and growth in
infancy, or overweight and obesity in later life?
2. What are the associations between introduction of
foods other than breast milk and growth in infancy,
or overweight and obesity in later life?
3. What is the association between duration of ex-
clusive breastfeeding/any breastfeeding and atopic
disease, asthma, or allergy?
4. What is the association between introduction of
foods other than breast milk and atopic disease,
asthma, or allergy?
5. What are the associations between duration of
exclusive breastfeeding/any breastfeeding and health
and disease outcomes in infancy and later in life, such
as: infectious diseases (otitis media, gastrointestinal
infections, and respiratory tract infections), cognitive
and neurological development, cardiovascular dis-
ease (CVD), cancer, diabetes, blood pressure, glucose
tolerance, and insulin resistance?
Limits: published since January 2000, human subjects.
See below for inclusion and exclusion criteria and
Appendix 1 for search terms.
Table 1. Reported breastfeeding rates (% exclusive and any breastfeeding) among children born in the Nordic countries (in Denmark little data
are available and only proportion of full breastfeeding at 1, 4, and 6 months is available)
1 w 1 m 2 m 3 m 4 m 5 m 6 m
9 m 12 m
Excl Any Excl Any Excl Any Excl Any Excl Any Excl Any Excl Any Any Any
Denmark1 95 80 60 12
Finland2 46 87 39 80 34 77 23 68 9 66 0 58 39 34
Iceland3 86 98 87 94 80 91 67 86 63 84 35 79 8 74 45 27
Norway4 82 95 73 91 63 88 46 85 25 82 9 80 63 46
Sweden5 83 97 67 87 51 76 11 63 34 16
1Children born in 2008 and 2009 in 14 municipalities in Denmark (4).
2Children born in 2010 Finland. Health and Welfare report 2012 (5).
3Children born in 200506 in Iceland. Nationwide randomized cohort (6) and in 200408, Directorate general of Health, Iceland (7).
4Children born in 2006 in Norway. National dietary surveys (8, 9).
5Children born in 2010 in Sweden. National statistics 2012 (10).
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Originally we also intended to include the effects of
breastfeeding on maternal health but due to time con-
straints it was decided to postpone this part.
Methods
Search terms
Search terms were defined during spring 2011, in col-
laboration with Sveinn Olafsson, librarian at Landspitali-
University Hospital, Reykjavik, Iceland. The search
terms are presented in Appendix 1.
Inclusion and exclusion criteria
The group focused on breastfeeding and the introduction
of solid foods to healthy, full-term children by healthy
mothers. Inclusion criteria in the abstract screening
process were the following: English or Nordic language,
study population relevant to the Nordic countries. Studies
were excluded if the exposure was pro- and/or prebiotics,
special formulas e.g. containing added long-chain poly-
unsaturated fatty acids (LC-PUFA), supplements to
mother or infants, contamination of breast milk e.g. lead
and mercury, if mother or child was sick at start or at
increased risk for disease, or if the outcome was other than
those stated in the research questions. Cross-sectional
studies only describing breastfeeding status without
relevant outcomes of interest for this review were also
excluded.
Dietary studies are often methodologically problematic
and studies on breastfeeding are no exception. It has been
shown that retrospective studies where parents are asked
to recall infant feeding data hava low reliability (13).
Studies with a recall periods longer than 3 years were
therefore excluded.
Due to the high rates of breastfeeding in the Nordic
countries, studies where breastfeeding was only defined as
never or ever breastfed, where the definition ever could
include everything between being put to the breast at the
maternity ward to several years of breastfeeding, were
deemed inapplicable for the Nordic recommendations
and these studies were excluded. However, the included
SLRs and meta-analyses (MAs) could include studies
with recall periods longer than 3 years or where breast-
feeding was only defined as never or ever breastfed.
Papers that were incorporated into an included SLR/
MA or published before the search years of an included
SLR/MA with the same outcome were excluded before
the full paper screening.
Search results
The final search was run in June 2011, including all
the relevant population groups and clinical outcomes,
resulting in 2,011 abstracts (Fig. 1). An additional 1,026
abstracts were classified as overviews or reviews but did
not include the description ‘systematic review’ or ‘meta-
analysis’ and we therefore decided (together with our
librarian) that these most likely were ‘overviews’ of the
area rather than proper systematic reviews, and these
were therefore not included. Abstract screening was
conducted in July and August 2011 according to the
guide for conducting SLRs for the 5th edition of the
NNR (14).
In total 416 full papers were ordered, including 40
SLR/MA. Of these 416 papers, 214 were immediately
excluded for the following reasons: 74 papers were
incorporated into an included SLR/MA, 70 papers were
published before the search years of an included SLR/
MA with the same exposure and outcome, 49 papers on
maternal health, eight commentaries, opinions or letters
to the editors, six overviews, six papers with a popula-
tion not applicable to Nordic countries today, and one
workshop. Full paper screening was conducted for the
remaining 202 publications SeptemberDecember 2011,
where 142 further papers were excluded. Reasons for
exclusion are provided in Appendix 2. Finally, 60 papers
were selected for quality assessment; 13 SLR/MA, 41
prospective cohort studies, and six originating from the
Promotion of Breastfeeding Intervention Trial (PROBIT)
study.
The PROBIT-study is a cluster-randomized interven-
tion trial in Belarus where geographical sites were
randomized to interventional breastfeeding promotion
or controls. The experimental intervention led to a large
increase in exclusive breast feeding at 3 months (44.3% v
6.4%; pB0.001) and a significantly higher prevalence of
any breastfeeding at all ages up to and including 12
months. Power calculation for the study was only
performed for the outcome gastroenteritis. Results from
the study are presented in several papers where either
differences between the intervention and control areas, or
between exclusive breastfeeding 3 months (EBF3) or 6
months (EBF6), or effects of duration of any breastfeed-
ing in months in relation to different outcomes are
described.
Detailed information about all graded SLR/MAs and
prospective cohort studies are found in Appendix 3 and 4,
respectively. Papers originating from the PROBIT-study
are presented in Appendix 4 together with the prospective
cohort studies.
In addition to these original papers, we included 13
reports originating from various organizations and
associations; American Academy of Pediatrics (AAP),
Committee on Toxicity of Chemicals in Food Consumer
Products and the Environment (COT), European Food
Safety Authority Panel on Dietetic Products, Nutrition
and Allergies (EFSA-NDA), European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN), EU FP6 project ‘The Prevalence, Cost and
Basis of Food Allergy Across Europe’ (EuroPrevall),
Scientific Advisory Committee on Nutrition (SACN),
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Swedish Pediatric Society, and the WHO. Details about
the included reports are given in Appendix 5.
A complementary search was conducted at the end
of January 2012 covering the period between the first
search until the end of December 2011. The abstracts
were similarly evaluated for full paper reading. Included
complementary papers were quality assessed and used
to evaluate the conclusion of the SLR, as supporting
or not.
Quality assessment, grading and reporting of evidence
The 60 included papers were quality assessed using the
Quality Assessment Tools (QAT) received from the NNR5
secretariat (14), which included a modified assessment of
multiple systematic reviews (AMSTAR) for assessment
of SLRs/MAs. These contained a number of questions
regarding several methodological aspects of the studies
including study design, population characteristics, expo-
sure and outcome measures, dietary assessment, and
confounders. The PROBIT-study papers were assessed as
prospective cohort studies.
The quality assessment resulted in the following grad-
ing; SLR/MA: 5A, 5B and 3C; prospective cohort
studies (including PROBIT): 1A, 43B, and 3C.
The findings for each separate outcome are pre-
sented in Supplementary Tables 111. Only studies
graded A and B are included in these tables, except for
Supplementary Table 6 which also includes two SLRs
graded C as the number of studies with cancer as the
main outcome was low.
All steps in the process of selecting and grading papers,
i.e. abstract screening, paper screening, and quality
assessment, was performed as described in the guide for
conducting SLRs. This meant that each abstract/paper
was evaluated by two experts. The experts first made an
individual appraisal which then was discussed and a joint
conclusion was made.
The grade of evidence was classified as convincing
(grade 1), probable (grade 2), limited-suggestive (grade
3), and limited-no conclusion (grade 4) depending on the
number and quality of supporting, non-supporting, and
contradicting studies.
Results
Nine of the 13 reports originating from various organiza-
tions and associations and published during recent years,
give a more general conclusion on the relationship
between breastfeeding and health outcomes and these
2011 abstracts identified 
in search 416 full text papers ordered
1595 exclude*
60 full papers–quality assessed
(some papers included more than 
one relevant outcome)
356 exclude* 
Abstract screening
*Exclusion criteria
1. Conducted in developing countries
2. Published before the search dates of 
the latest systematic review (SLR) or 
meta-analysis (MA) or included in it.
3. Preterm babies
4. Babies non-healthy at inclusion
5. Non-human studies
6. Non-English or non-Nordic 
publications
7. No outcome of interest
8. Exposure not relevant (breastfeeding 
only given as ever-never,  
breastfeeding data collected 
retrospectively after >3 y of age, or 
breastfeeding only adjusted for)
Full text screening 
Growth, 
over-
weight, 
obesity
24
Blood 
pressure
4
S-cholesterol
2
AOM, GII, LRI
7
Cancer
3
Atopic 
disease
13
Asthma
15
Neuro-
logical 
function, 
IQ
7
Celiac 
disease
1
IBD
1
Diabetes
3
Type 1
2
Type 2
1
SLR/MA 
2A, 2B
Cohort 
1A, 19B
SLR/MA 
1A
Cohort 
3B
SLR/MA 
2A
SLR/MA 
1A
Cohort 
1B
SLR/MA 
1A
SLR/MA 
2A, 1B
Cohort 
4B
SLR/MA 
1A, 2C
SLR/MA 
1A, 2B
Cohort 
10B
SLR/MA 
1A, 2B
Cohort 
12B
SLR/MA 
1A
Cohort 
6B
SLR/MA 
1A
SLR/MA 
1A
4C-studies 
excluded from 
further analysis 
Fig. 1. Overview search results of SLR on breastfeeding/introduction of other foods and health outcomes.
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conclusions are summarized here in the paragraphs
below. Conclusions on specific diseases are given in the
relevant chapters.
AAP (15, 16), EFSA (17), ESPGHAN (18, 19), SACN
(20), and WHO (21), all conclude that breastfeeding
and the use of human milk confer unique nutritional and
non-nutritional benefits to the infant and the mother
and, in turn, optimize infant, child, and adult health
as well as child growth and development. These organi-
zations reaffirm their recommendations of exclusive
breastfeeding for approximately 6 months, followed by
continued breastfeeding as complementary foods are
introduced, with continuation of breastfeeding up to 1
year or longer [WHO (21)  2 years or longer] as mutually
desired by mother and infant.
EFSA (17) and ESPGHAN (19) have looked into the
risks of introducing complementary feeding before 6
months of age. EFSA (17) states that the introduction
of complementary food in the diet of healthy term infants
in the EU, between the ages of 4 and 6 months, is safe
and does not pose a risk for adverse health effects.
ESPGHAN Committee on Nutrition adds that comple-
mentary feeding should not be introduced before 17
weeks and not later than 26 weeks (19), and that partial
breastfeeding as well as breastfeeding for shorter periods
of time are also beneficial (18).
All these organizations agree that strategies that
protect, support and promote exclusive breastfeeding
for the first 6 months of an infant’s life should be
encouraged and also recognize the benefits for long-term
health.
General growth and overweight/obesity
Supplementary Table 1 shows a summary of studies with
the main outcome growth and overweight/obesity (details
are provided in Appendix 35). In total, 23 papers were
chosen in the systematic review process to be evaluated
for the evidence of an association between breastfeeding
and weight development, i.e. later overweight or obesity.
Of those, 19 were prospective cohorts (including birth
cohorts) and four were SLR/MA. Three relevant reports
are also described.
SLR/meta-analysis
Ip et al. (22) conducted a SLR graded A, including 3 SLR
or meta-analysis (a total of 61 studies: 35 observational,
18 cohort, seven cross-sectional, one case-control), on
overall breastfeeding (defined as ever vs. never, in one
study breastfeeding2 months vs. never) and over-
weight. Ip et al. concluded that a history of breastfeeding
was associated with reduced risk of obesity in childhood
and/or adult life, but state that the observed association
could reflect selective reporting and/or publication bias.
Pooled adjusted odds ratio (OR) was 0.76 (95% con-
fidence interval [CI]: 0.67, 0.86), 0.93 (95% CI: 0.88, 0.99)
and 0.96 (95% CI: 0.94, 0.98) in three included studies for
those breastfed compared with never breastfed.
The SLR by Kramer and Kakuma (2), graded A,
included only controlled clinical trials and observational
studies. The aim was to examine whether or not exclusive
breastfeeding for 6 months had an impact on growth (and
other outcomes). They concluded that infants breastfed
exclusively for 6 or more months had no observable
deficits in growth (up to 12 months of age).
Monasta et al. (23) studied the evidence for early-life
determinants of obesity (to 5 years of age) in a review of
systematic reviews. They reported that no/short breast-
feeding was one of five factors associated with overweight
and obesity in childhood and/or adult life. This was
supported by better-quality reviews. They included 22
reviews of which eleven were of moderate quality and
eleven of low quality. Articles published after the reviews
were used to confirm results. They concluded that
breastfeeding may be a protective factor against over-
weight and obesity. For odds ratios, see Supplementary
Table 1.
An SLR by Moorcroft et al. (24) did not find any clear
association between the age of introduction of solid foods
and obesity in infancy and childhood. In total, 24 papers
were included in the SLR (one RCT, re-analysis of data
from two RCTs, 20 cohort studies and one case-control
study). Eight papers measured outcomes up to 1 year of
age; one found a positive association between early
introduction of solids and weight at 6 months, one found
a positive association at 6 months but not at 1 year, three
found a positive association at 1 year and three found
no association between age at introduction and later
weight. Nineteen papers measured outcomes after 1 year
and up to 18 years of age (one also mentions 42 years of
age). Of these, four found a positive association between
early introduction of solids and later weight, while the
remaining 15 found no association. The reverse was never
seen.
Prospective cohort studies
The WHO working group on the Growth Reference
Protocol and the WHO Task Force on Methods for the
Natural Regulation of Fertility (25) aimed to study the
impact of timing, frequency and type of complementary
foods in a prospective study. The study was graded B. Five
to seven hundred mothers and infants were recruited
within the first week after birth in all seven countries (only
two were Western countries) to be prospectively followed
for 8 months. Study site was adjusted for in the analysis,
but no major differences in growth related to breastfeed-
ing were seen. Analysis performed on data from 1,252
infants showed significantly slower growth (both length
and weight) during the first 4 months for those infants
given complementary food before the age of 4 months
compared to those introduced to complementary foods
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between 4 and 6 months of age. Infants who were given
complementary foods after reaching 6 months of age had
significantly slower length velocity from 4 to 8 months of
age when compared to those given complementary foods
between 4 and 6 months of age. Concerning analysis of
type and frequency of complementary foods and breast-
feeding, from 4 to 6 months of age the frequency of
receiving solid foods was positively associated with length
velocity and the frequency of breastfeeding negatively
with weight velocity. Based on the modest but significant
effects found, the authors concluded that the results did
not provide adequate evidence of benefit or risk related to
timing of complementary foods and growth nor to
differential types and frequencies of complementary foods
between 4 and 6 months of age in healthy infants living in
environments without major economic restraints and low
rates of illness.
Aarts et al. (26) published a sub-study of the WHO
multicentre study (25) to test exclusive vs. non-exclusive
breastfeeding in Sweden. The study was graded B. The
conclusion of this study was that truly exclusively
breastfed children for the first 6 months grew similar
to those not exclusively breastfed from the age of 34
months (however the latter group had also a high rate of
breastfeeding).
Chivers et al. (27) reported an analysis from the Raine
pregnancy cohort from Western Australia which showed
a significantly higher frequency of overweight and obesity
when breastfeeding was stopped before 4 months of age
vs. continued breastfeeding for a longer period of time.
Similar results were found when analyzing the introduc-
tion of other milk before the age of 4 months vs. after.
Body mass index (BMI, kg/m2) was measured at the age
of 1, 2, 3, 6, 8, 10, and 14 years and found to be higher
over time for those breastfed shorter than 4 months or
given other milk before that age. The authors concluded
that early infant feeding was important for timing of
adiposity rebound, and that early infant feeding had
effects on BMI up to the age of 14 years. Their findings
support the importance of exclusive breastfeeding for
duration longer than 4 months.
Cole et al. (28) used a sub-sample (n120) of the
Cambridge Infant Growth Study to construct new median
weight curves for breastfed infants and compare it with
the British 1990 reference curve. The infants were fed
breast milk (with no formula) for at least 24 weeks, with
solids introduced at a mean age of 15 weeks. They
concluded that the British 1990 reference curves re-
flected the growth of long-term breastfed infants only
imperfectly, with mean weight for these infants falling
by 0.5 standard deviation scores (SDS) from 2 to 12
months.
De Hoog et al. (29) studied ethnic differences in growth
(SDS weight, length, weight-for-length) during first 6
months among infants born in the Netherlands. Infant
feeding was defined as duration of breastfeeding: (none,
1 month, 13 months, 46 months, and 6 months); age
at the introduction of formula feeding (none, 1 month,
13 months, 46 months, and6 months); age at the
introduction of complementary food (B4 months, 4
months, 5 months, and5 months). The growth rate
was higher in almost all ethnic minorities, with b between
0.07 and 0.41 for weight and between 0.12 and 0.42 for
length, compared with ethnic Dutch infants. In general,
exclusive breastfeeding for 4 months was associated with
slower growth for all three growth measures compared
with those not exclusively breastfed. Feeding factors
explained a small degree of the higher weight and length
gain in infants of African descent, but not a higher SDS
weight-for-length in the Moroccan population.
De Kroon et al. (30) studied the association between
duration of exclusive breastfeeding on BMI and body fat
at 1828 years of age (estimated by validated question-
naire) in the Netherlands. Infant feeding practices were
recorded during repeated health visits in infancy, but
definition of exclusive breastfeeding only included not
giving infant formula and other foods were not consid-
ered. Significant inverse dose-response of breastfeeding
duration was found for BMI (b0.13, SE 0.06), waist
circumference (b0.39, SE 0.18) and waist-hip-ratio
(b0.004, SE 0.001) after correction for age, gender,
and confounders. A relation between exclusive breast-
feeding and more positive dietary behavior was also
reported.
Another Dutch study, Durmus et al. (31) found no
association between the duration of any or exclusive
breastfeeding with growth rates between 0 and 3 months.
Shorter breastfeeding was associated with increased gain
in age- and sex adjusted SDS for length, weight, and BMI
between 3 and 6 months (p for trend B0.05). Similar
tendencies were seen for breastfeeding exclusivity. Breast-
feeding duration and exclusivity were not consistently
associated with risk of overweight and obesity at 1, 2, and
3 years of age.
Gubbels et al. (32) compared weight gain in the
first year, and BMI and overweight up to age 4 years
between breastfed and formula-fed infants in the
KOALA Birth Cohort Study from the Netherlands.
Breastfeeding duration was studied up to 12 months of
age. Each additional month of breastfeeding was asso-
ciated with less weight gain in the first year (b37.6, pB
0.001), a lower BMI z-score at age 1 (b0.02, pB0.01),
and lower odds of being overweight at 1 year of age
(OR0.96, pB0.05). No significant associations be-
tween breastfeeding and BMI or overweight were found
at ages above 1 year.
In a prospective cohort, Huh et al. (33) studied
introduction of solid foods atB4 months of age, 45
months of age or]6 months separately among infants
breastfed more than 4 months, never breastfed, or
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stopped breastfeeding before 4 months of age (formula
feds) and possible obesity at 3 years of age. Among
breastfed infants timing of solid food was not associated
with obesity at 3 years of age (OR 1.1 [95% CI: 0.3, 4.4]).
Among formula-fed infants (or weaned before 4 months
of age), introduction of solid foods before 4 months of
age was associated with obesity at 3 years of age (OR 6.3
[95% CI: 2.3, 6.9]), but it was not explained by rapid early
growth.
Kalies et al. (34) found in a prospective cohort from
Germany that those who were exclusively breastfed
B6 months had a greater risk of elevated weight gain at
2 years of age compared with children breastfed for
6 months and more (OR 1.65 [95% CI: 1.17, 2.30]).
However, they do not include solids in their definition of
exclusive breastfeeding. Duration of exclusive breast-
feeding was inversely associated with the risk of ele-
vated weight gain in a strongly duration-dependent way.
Infants exclusively breastfed51 months had twice as
often elevated weight gain (OR 1.99 [95% CI: 1.34, 2.97])
compared to infants breastfed ]6 months. Duration of
exclusive breastfeeding was defined as the number of
months breastfed without concomitant feeding of infant’s
formula and classified a priori as B6 months or ]6
months, and for dose-response-analysis in the categories:
01 months, 23 months, 45 months, ]6 months.
In another prospective cohort study, Kitsantas and
Gaffney (35) found that preschoolers with normal BMI
had been breastfed longer than their overweight/obese
peers (mean [SD]: 1.9 [2.7] months vs. 1.7 [2.5] months).
However, while shorter duration of breastfeeding did
emerge as a risk, it was not a significant predictor in the
logistic regression analysis.
Three papers from the PROBIT-study focus on various
indicators of growth. In a paper from 2007, including
13,889 of 17,046 total participants, Kramer et al. (36)
found no significant intervention effects at 6.5 years on
adiposity, stature, height, waist or hip circumference,
triceps or subscapular skinfold thickness. They conclude
that previously reported beneficial effects on these out-
comes may be the result of uncontrolled confounding and
selection bias. However, in a later paper from 2009 (37)
which included 2,951 of 3,483 total participants followed
during the first year, they report that BMI, triceps
skinfold thickness, and hip circumference at the age of
6.5 years were higher among children exclusively
breastfed for 6 months compared with those exclusively
breastfed for 3 months. Another study from Kramer et al.
(38) concluded that smaller size (especially weight for
age) was strongly associated with increased risks of
subsequent weaning and discontinuing exclusive breast-
feeding (adjusted OR 1.21.6), especially between 2 and 6
months of age, even after adjustment for potential
confounding factors and clustered measurement.
Oddy et al. (39) reported that infants overweight at
52 weeks were more likely to have been given formula
feeds at an earlier age than normal weight infants. Infants
who had been fully breastfed for at least 4 weeks were
lighter (9,731 g vs. 10,138 g; p0.041) and shorter (73.7
cm vs. 75.6 cm; p0.001) than infants who had received
infant formula by 4 weeks. These results were stronger for
boys and for babies less than 3,500 g at birth.
Rebhan et al. (40) described the effects of the applica-
tion of the WHO recommendation of exclusive breast-
feeding to 6 months of age on infants’ growth up to
the age of 9 months. The mothers were retrospectively
questioned about breastfeeding when their children were
9 months old. Those breastfed shorter than 4 months
showed lower weight-for-length z-scores in the first
days of life and higher z-scores in months 6 and 7 than
those exclusively breastfed for longer than 4 months. No
significant difference in growth was found between those
exclusively breastfed for 46 months vs. 6 months or more.
Rzehak et al. (41) evaluated the effect of exclusive
breastfeeding for 4 months on weight, length, and BMI
by regular measurements up to the age of 6 years. Those
exclusively breastfed for 4 months gained less weight, but
grew equally in length in the first 12 months of life vs.
those children on mixed feeding or only formula. Length
velocities were not different between the groups. Over
time, a slightly lower risk (difference B2%) of being over-
weight was estimated for infants exclusively breastfed
for 4 months. The protective effect of breastfeeding on
becoming overweight was related to its weight-velocity-
modifying-effect in early infancy. The drawback of this
study is that it does not take different duration of
breastfeeding beyond 4 months into account.
Scholtens et al. (42) found that children breastfed for
more than16 weeks had a lower BMI at 1 year of age than
non-breastfed infants (after adjustment for confounders;
b0.22, 95% CI: 0.39, 0.06). The association
between breastfeeding and BMI between 1 and 7 years
of age was negligible, while a high BMI at 1 year of age
was strongly associated with a high BMI between 1 and 7
years of age in the same model. These findings suggest
that the lower BMI and lower risk of overweight among
breastfed children later in life are already achieved at
1 year of age. In a later follow-up of the same children,
Scholtens et al. (43) reported that breastfeeding for over
16 weeks was significantly associated with a lower over-
weight risk at 8 years [OR 0.67 (95% CI: 0.47, 0.97)], and
the association hardly changed after adjustment for diet
[OR 0.71 (95% CI: 0.49, 1.03)].
Van Rossem et al. (44) reported that at the age of
3 years, adjusted BMI z-score of fully breastfed infants at
6 months was 0.17 (95% CI: 0.43, 0.09) units lower
than those never breastfed. After additional adjustment
for infant weight change, the estimate for BMI z-score
was attenuated (0.03, 95% CI: 0.27, 0.20). Similar
The 5th Nordic Nutrition Recommendations
Citation: Food & Nutrition Research 2013, 57: 20823 - http://dx.doi.org/10.3402/fnr.v57i0.20823 7
(page number not for citation purpose)
results were seen with the sum of subscapular (SS) and
triceps (TR) skinfold thicknesses. For each month a child
was breastfed until the age of 6 months, the decrement in
BMI z-score was 0.04 units (95% CI: 0.07, 0.01) and
the decrement in SSTR was 0.19 mm (95% CI: 0.31,
0.07) and the odds of being obese was reduced by 8%
(95% CI: 2%, 18%).
Reports
SACN (20) conclude that infants who are breastfed are
less likely to be obese in later life.
A report from WHO (21) states that the risk for
overweight/obesity in childhood and adolescence was
20% (19 year) to 30% (919 year) lower among breastfed
subjects compared with non-breastfed. Difference for
19 years was not significant and the pooled OR was
(95% CI) 0.79 (0.710.87), 0.69 (0.600.80), and 0.88
(0.741.04), respectively.
WHO undertook the Multicentre Growth Reference
Study between 1997 and 2003 to generate new curves for
assessing the growth and development of children the
world over using breastfed children as the norm (45).
Primary growth data and related information were gath-
ered from 8,440 healthy breastfed infants and young
children from widely diverse ethnic backgrounds and
cultural settings (i.e. Brazil, Ghana, India, Norway,
Oman, and USA). The study resulted in new growth
charts showing slower growth of the breastfed infants
from about 23 months of age compared to previous
international growth charts of infants given formula and
other food.
Conclusion
The majority of studies included in the present SLR
reported duration of breastfeeding without distinguishing
between the time children were exclusively and partially
breastfed. In addition age of outcome measurements
varied: during the first year of life (seven studies),
toddlers/preschool age (10 studies) and from school-age
up to adulthood (six studies, including one with varied
ages).
Exclusive or any breastfeeding and growth in infancy
Seven studies reported associations of exclusive breast-
feeding, either as a continuous variable or for 3, 4, or
6 months, with growth. Four studies found no difference
in growth between those exclusively breastfed for 4
months or 6 months (2, 25, 26, 40). Rebhan et al. (40)
also found that those exclusively breastfed less than 4
months showed higher weight-for-length z-scores at 67
months compared with those exclusively breastfed for
4 months or longer.
Two studies found that infants exclusively breastfed for
4 months showed slower growth during the first 6 months
(29) or 36 months (31) compared with those with shorter
breastfeeding. Similarly, Rzehak et al. (41) found that
infants exclusively breastfed for 4 months gained less
weight, but grew equally in length in the first 12 months
of life vs. children on mixed feeding or only formula.
Kramer et al. (38) found that smaller size (especially
weight for age) was strongly associated with increased
risks of subsequent weaning and discontinuing exclusive
breastfeeding (adjusted OR 1.21.6), especially between
2 and 6 months of age.
Exclusive breastfeeding and risk of overweight/obesity
Three prospective cohort studies found a lower risk of
overweight or obesity with longer duration of exclusive
breastfeeding. Oddy et al. (39) found that infants who
had been fully breastfed for at least 4 weeks were lighter
and shorter at 52 weeks than infants who had received
infant formula by 4 weeks. Rzehak et al. (41) found a
slightly lower risk (difference B2%) of being overweight
at 6 years of age for those exclusively breastfed for 4
months compared with children on mixed feeding or
only formula. Additionally, Huh et al. (33) found that
earlier introduction of solids among children fed formula
before 4 months of age was associated with obesity at 3
years of age, but among breastfed infants the timing of
introduction of solid foods was not associated with
obesity.
In contrast, Durmus et al. (31) found no consistent
association between breastfeeding duration and exclusiv-
ity with risk of overweight and obesity at age 1, 2, and
3 years, and Kramer et al. (37), reported that BMI,
triceps skinfold thickness, and hip circumference at 6.5
years of age were higher among children exclusively
breastfed for 6 months compared with those exclusively
breastfed for 3 months.
Duration of breastfeeding and risk of overweight/obesity
One SLR and eight prospective cohort studies show lower
risks of overweight and/or obesity with longer breastfeed-
ing duration. Chivers et al. (27) found a higher BMI over
time up to 14 years of age for those breastfed shorter than
4 months or given other milks before this age. De Kroon
et al. (30) found a significant inverse dose-response of
breastfeeding duration for BMI and body fat at 1828
years of age. Gubbels et al. (32), studied breastfeeding
duration up to 12 months of age and found that each
additional month of breastfeeding was associated with
less weight gain, a lower BMI z-score at age 1 year, and
lower odds of being overweight in the first year of life, but
not at ages above 1 year. Kalies et al. (34) found that
those who were breastfed B6 months had a greater risk
of elevated weight gain at 2 years of age compared with
those exclusively breastfed for 6 months or longer. They
also found that duration of exclusive breastfeeding1 was
1Solids not included in definition.
Agneta Ho¨rnell et al.
8
(page number not for citation purpose)
Citation: Food & Nutrition Research 2013, 57: 20823 - http://dx.doi.org/10.3402/fnr.v57i0.20823
inversely associated with the risk of elevated weight gain
in a strongly duration-dependent way. Monasta et al.
(23), concluded that breastfeeding may be a protective
factor against overweight and obesity. Kitsantas and
Gaffney (35) found that preschoolers with normal BMI
had been breastfed longer than their overweight/obese
peers. Scholtens et al. found that compared with non-
breastfed children, those breastfed for more than 16
weeks had a lower BMI at 1 and 8 years of age (43), but
not at age 7 (42). Van Rossem et al. (44) found that for
each month a child was breastfed until the age of 6
months, the odds of being obese at 3 years was reduced
by 8% (95% CI: 2%, 18%).
In contrast, Kramer et al. (36) found no significant
differences between the intervention area and the control
area at 6.5 years on growth indices and suggest that
previously reported beneficial effects on these outcomes
may be the result of uncontrolled confounding and
selection bias.
An SLR by Moorcroft et al. (24), studied age of intro-
duction of solid foods and obesity and found no clear
associations.
Based on the above, we conclude that growth in infancy
(length and height) varied only a little between those
exclusively breastfed for 4 months or 6 months. None-
theless, there is probable evidence (grade 2) that exclusive
breastfeeding for longer than 4 months is associated with
slower weight gain during later infancy compared with
those exclusively breastfed for less than 4 months of
age. This is also supported by the new WHO child
growth standards (45), when compared to the old inter-
national growth reference, which was mainly based on
non-breastfed infants.
The evidence is convincing (grade 1) that longer
duration of exclusive breastfeeding or any breastfeeding
is associated with a protective effect against overweight
and obesity in childhood and adolescence. This is also
supported by SACN (20) and WHO (21). To further
the conclusion, three studies show a dose-response
relationship with longer duration giving more protection
(30, 32, 34).
With regard to the association with overweight/obesity
in adulthood, due to a scarcity of strong studies, we judge
the evidence as limited-suggestive (grade 3) for a protec-
tive effect of breastfeeding.
Blood pressure
Supplementary Table 2 shows studies with outcome
blood pressure during childhood and/or later in life
(details are provided in Appendix 35). In total four
papers were chosen in the systematic review process to be
evaluated for the evidence of an association between
breastfeeding and blood pressure. Three of those were
prospective cohorts (including birth cohort), all graded B,
mainly due to a lack of power calculations, and one was a
meta-analysis, graded A. There are also two reports
on the associations on breastfeeding and blood pressure
(20, 21).
SLR/meta-analysis
Ip et al. (22) performed a SLR (A-graded) on two MAs
graded B, one of which included the age group 160 years
and the other 171 years. In total the two MAs included 24
studies of various design (observations within randomized
controlled trials [RCTs], prospective cohorts, retrospective
cohort, and cross-sectional studies), 13 of the studies were
included in both MAs. Ip et al. did not combine the two
meta-analysis but concluded that systolic blood pressure in
age groups 160 years and 171 years were lower by 1.4
(95% CI: 2.2, 0.6) and 1.10 (95% CI: 1.8, 0.4),
respectively, in the group of breastfed compared with
formula fed. The same trends were seen in diastolic blood
pressure, which was lower among breastfed (age group
160 years 0.5 [95% CI: 0.9, 0.04] and 171 years
0.36 [95% CI: 0.79, 0.08]). Although both MAs had
moderate methodological quality and reported similar
findings, the authors had different appraisals of the public
health importance of the small reduction in systolic blood
pressure. Ip et al. therefore concluded that a history of
breastfeeding during infancy has small reductive effect to
adult blood pressure, but the clinical or public health
implication of the finding is unclear.
Prospective cohort studies
De Jonge (46) compared left cardiac structures and
blood pressure at 2 years of age among three groups of
children; never breastfed, partially breastfed, and exclu-
sively breastfed for ]4 months. They found no differ-
ences in cardiac structures and blood pressure at age
2 years between breastfed and non-breastfed children.
Duration and exclusivity of breastfeeding was not con-
sistently associated with outcomes.
Two papers from the PROBIT-study (36, 37), focus on
blood pressure at the age of 6.5 years and found no
significant differences in blood pressure neither between
the intervention and the control areas (36) nor between
those exclusively breastfed for 3 months vs. 6 months (37).
Reports
It is stated in a WHO report from 2007 (21) that subjects
who were breastfed experienced lower mean blood pres-
sure in later life. The difference was statistically signifi-
cant, but the magnitude was relatively modest (decreased
by slightly more than 1 mmHg).
Similarly, in a report from 2011, SACN (20) conclude
that infants who are breastfed tend to have slightly lower
blood pressure although there is inconsistent evidence
that breastfeeding influences subsequent cardiovascular
mortality.
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Conclusion
The SLR by Ip et al. (22) (including 24 studies) found an
association between breastfeeding and lower systolic
blood pressure. The three prospective studies found no
association between feeding history and blood pressure
in childhood. However, the two reports below found the
evidence to be in line with the SLR by Ip et al. (22); that
is, breastfeeding has a small but significant reductive
effect on blood pressure. In the present SLR, we therefore
judge that there is (at least) probable evidence (grade 2)
for this association.
Serum cholesterol
Supplementary Table 3 shows two SLRs, both graded A,
chosen in the systematic review process to be evaluated
for the evidence of an association between breastfeeding
and later cholesterol levels (details are provided in
Appendix 3). There are also two reports on the associa-
tions on breastfeeding and serum cholesterol in adult-
hood (20, 21).
SLR/meta-analysis
Ip et al. (22) reviewed if breastfeeding (ever vs. never) is
associated with cholesterol levels in infancy (B1 year),
childhood/adolescence (116 years) and/or adulthood
(1765 years). They looked at one meta-analysis (graded
C) including 27 cohort and 13 cross-sectional studies;
infants (26 studies), children/adolescents (17 studies), and
adults (nine studies). In 25 of 26 observations, infants
who were breastfed had higher mean total cholesterol
levels compared with infants who were formula-fed. In 16
of 17 observations in children or adolescents, the mean
total cholesterol levels for those who were breastfed in
their infancy were similar to those who were formula-fed.
In seven of nine observations on adults, lower mean total
cholesterol levels were reported for those breastfed in
their infancy compared with those who were formula-fed.
However, Ip et al. state that no conclusions could be
drawn about the evidence based on this meta-analysis
since it was graded C (due to data based on individuals
with a wide age range, gender, and other confounders
were not explicitly analyzed, no detailed information (e.g.
fasting or not fasting) on the collection of specimen for
cholesterol testing included).
Owen et al. (47) performed a SLRand examinedwhether
breastfeeding is associated with lower total cholesterol
concentrations in adulthood. They explored data from 17
studies (10 prospective cohorts, four cross-sectional, two
historical cohorts, one retrospective cohort) and found
that ever breastfed had lower cholesterol levels than those
never breastfed (0.04 mmol/L [95% CI: 0.08, 0.00],
p0.037). The difference in cholesterol between infant
feeding groups was larger (p0.005) and more consistent
in seven studies that analyzed ‘exclusive’ feeding patterns
(0.15 mmol/L [95% CI: 0.23, 0.06]) than in ten
studies that analyzed non-exclusive feeding patterns
(0.01 mmol/L [95% CI: 0.06, 0.03]).
Reports
A WHO report from 2007 (21) states that subjects who
had been breastfed experienced lower total cholesterol
compared with non-breastfed. The difference was statisti-
cally significant, but the magnitude was relatively modest
(mean difference:0.18; 95% CI:0.30,0.06 mmol/L).
Similarly, in a report from 2011, SACN (20) concluded
that infants who are breastfed tend to have slightly lower
total serum cholesterol concentrations in adult life
although there is inconsistent evidence that breastfeeding
influences subsequent cardiovascular mortality.
Complementary search
Bekkers et al. (48), graded B, investigated the influence of
breastfeeding and other perinatal risk factors on total
and high density lipoprotein (HDL) cholesterol concen-
trations (non-fasting state) in 8-year-old children in the
PIAMA birth cohort study in the Netherlands. Total
breastfeeding duration was assessed in infancy and
categorized as no breastfeeding, breastfeeding for 116
weeks, or breastfeeding for 16 weeks or longer. No
significant associations were found between breastfeeding
and total cholesterol or HDL concentrations.
Conclusion
Both SLRs included in the present SLR (22, 47) showed
that breastfeeding might be beneficial and have lowering
effects on blood cholesterol concentrations in adulthood,
although Ip et al. (22) concluded that the quality of
the meta-analysis was too poor to draw conclusions
from. However, two reports, WHO 2007 (21) and SACN
2011 (20) found a small but consistent relation between
breastfeeding and lower blood cholesterol later in life. In
the present SLR, we judge it to be (at least) probable
evidence (grade 2) for a small reduction on blood
cholesterol in adulthood from breastfeeding but there is
less evidence for an association between breastfeeding
and blood cholesterol in childhood. This conclusion is
supported by a recent paper of Bekkers et al. (48) on
cholesterol in childhood, found by the complementary
search to the present SLR.
Diabetes mellitus (T1DM and T2DM)
Supplementary Table 4 shows studies with outcome
diabetes type 1 (T1DM) and type 2 (T2DM) (details
are provided in Appendix 35). In total, two papers were
chosen in the systematic review process to be evaluated
for the evidence of an association between breastfeeding
and diabetes. Of those, one was a prospective cohort (49),
and the other was a meta-analysis (22) including both
T1DM and T2DM as outcomes. There was also one
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report on the associations on breastfeeding and T1DM
(20) and two on T2DM (20, 21).
SLR/meta-analysis
Ip et al. (22) summarize two meta-analysis (performed in
1994 and 1996, respectively) and six later studies on the
association between breastfeeding and the risk of T1DM.
The two meta-analysis were of fair quality and included a
total of 17 case-control studies reported OR 1.23 (95%
CI: 1.12, 1.35) and 1.43 (95% CI: 1.15, 1.77), respectively,
for the risk of T1DM if breastfeeding duration was less
than 3 months compared to breastfeeding for more than
3 months. Five of the six later studies show similar
results; however, these were retrospective case-control
studies. Comparison of ORs between studies with long-
term recall of breastfeeding data and those more recent
showed significant differences in T1DM risk only with
long-term retrospective data.
Ip et al. (22) also looked at T2DM in a pooled analysis
of seven studies (three historical cohort, two cross-
sectional, one prospective cohort, and one case-control
studies). Pooled adjusted OR was 0.61 (95% CI: 0.44,
0.85) for those breastfed compared with formula fed.
However, only three of the seven studies had information
about important confounders, and although these three
studies concluded that adjustment did not alter crude
estimate, the authors do not feel confident that all
potential confounders have been ruled out.
Prospective cohort studies
Couper et al. (49) followed prospectively an Australian
birth cohort of 548 infants (Baby Diab study, Melbourne)
until 6 years of age to investigate the relationship between
early growth and infant feeding and the risk of islet cell
autoimmunity. They analyzed breastfeeding, exclusive
and total as none, duration 03 months, and duration
3 months. They also evaluated the time of introducing
cow’s milk, gluten-, and non-gluten food as well as
breastfeeding at introduction of cereals and cow’s milk.
Unfortunately there was a significant amount of missing
data in the diet records restricting the power of the
analysis and as noted by the authors, an effect could have
been missed. The study showed no effect of breastfeeding
or other diet variables, but being above average in weight
in early life, especially the first 2 years, increase the risk of
islet cell autoimmunity in children with a first degree
relative with T1DM. The authors point out the interac-
tion between the diet and weight gain, including that
formula-fed infants gain more weight from 3 months of
age compared to breastfed infants (two studies). They
also discuss that it is not possible to reconcile variable
findings of infant diet effects on the development of islet
autoimmunity (seven studies), such as early introduction
of cow’s milk and cereals, by an overriding risk of weight
gain (three studies). A limitation of the study is the
outcome measure of islet autoimmunity rather than
T1DM.
Reports
With regard to T1DM, EFSA (17) state that present
available data on the risk of T1DM support the belief that
gluten containing foods should be introduced not later
than 6 months of age, preferably while still breastfeeding.
In a joint statement, COT/SACN (50) refute EFSA’s
conclusion on the introduction of gluten into the infant
diet no later than 6 months of age with the aim of
reducing the risk of subsequent development T1DM (17).
COT/SACN (50) do not consider the evidence sufficient
to support the precise statement about age, but considers
the evidence strong for the protective effects of introduc-
tion of gluten while breastfeeding is continued.
With regard to T2DM, SACN (20) and WHO (21)
both state that infants who are not breastfed are at
greater risk of type 2 diabetes.
Conclusion
In conclusion, longer duration of breastfeeding may con-
tribute to risk reduction in the development of T1DM
according to a number of retrospective studies collected
in a SLR (22). Longer breastfeeding seem to decrease the
risk more than short-term breastfeeding. With regard to
the reports by EFSA (19) and COT/SACN (50), intro-
duction of gluten containing foods while still breastfeed-
ing gives some protection against T1DM. Breastfeeding
could also be considered a modifiable risk factor for the
development of T2DM, and in the reports by SACN (20)
and WHO (21) both state that infants who are not
breastfed are at greater risk of T2DM.
In the present SLR, we therefore conclude that the
evidence for any breastfeeding having a protective effect
against T1DM and T2DM is probable (grade 2). The
evidence for a stronger protective effect for longer
duration of breastfeeding is still limited but suggestive
(grade 3). It is unclear whether the positive effects seen
for breastfeeding depend on the breast milk itself, on the
avoidance of other foods given to infants, or on other
factors that have been suggested in literature such as
lower prevalence of infections in the breastfed child (see
below).
Acute otitis media, gastrointestinal infection, lower
respiratory infection
Supplementary Table 5 shows studies with outcome acute
otitis media (AOM), gastrointestinal infection (GI), and
lower respiratory infection (LRI). In total, seven papers
were chosen in the systematic review process to be
evaluated for the evidence of an association between
breastfeeding and infections. Of those, four were pro-
spective cohorts (including birth cohort) and three were
SLRs/MAs (of which two were graded A).
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SLR/meta-analysis
Dujits et al. did a SLR (51), graded B due to no power
calculation, including 21 studies from industrialized
countries (defined by the World Bank as high income)
(case-control, follow-up or randomized control trials);
eight studies on GI and 16 studies on LRI with duration
of follow-up 030 days and 024 months, respectively.
Six out of eight studies suggested that breastfeeding had
a protective effect on GI (the size of the effect varied
according to duration and exclusiveness of breastfeed-
ing), and 13 out of 16 studies concluded that breastfeed-
ing had a protective effect against LRI. Five studies
combined duration and exclusiveness of breastfeeding.
All those studies observed a protective dose/duration-
response effect on gastrointestinal or respiratory tract
infections. These studies strongly suggest that breastfeed-
ing protects infants against overall infections and gastro-
intestinal and respiratory tract infections in industrialized
countries. The definitions of breastfeeding varied in the
included studies and no description of the methodology
used to assess dietary intake was given.
The A-graded SLR by Ip et al. (22), concluded that
breastfeeding was associated with significant reduction
in AOM, although only four of the five cohort studies
included in the meta-analysis had clear definitions on
feeding practices. For the final analysis infant feeding was
dichotomized into two groups; exclusive breastfeeding
and partial/mixed feeding vs. exclusive artificial feeding.
Pooled adjusted OR of risk for AOM when comparing
ever breastfed with never breastfed was 0.77 (95% CI:
0.64, 0.91). Comparing exclusively breastfed infants for
3 or 6 months compared with never breastfed gave a
pooled adjusted OR 0.50 (95% CI: 0.36, 0.70). Results
were conflicting for GI and the 16 studies (12 prospective
cohort, two retrospective cohort, two case-control) in-
cluded in a meta-analysis were graded B and suffered
from various methodological flaws. For LRI a meta-
analysis was done including seven cohort studies, the
relative risk (RR) of hospitalization due to LRTIB1 year
in those exclusively breastfed 4 months or more com-
pared with formula-fed infants was 0.28 (95% CI: 0.14,
0.54).
Another A-graded SLR, Kramer and Kakuma (2),
compared exclusive breastfeeding for 6 months vs.
exclusive breastfeeding for 34 months with mixed
breastfeeding including 22 studies from 11 developing
and 11 developed countries (controlled clinical trials and
observational studies). They reported that infants who
continued exclusive breastfeeding for six months had a
significantly reduced risk of one or more episodes of GI
(RR 0.67 [95% CI: 0.46, 0.97]).
Prospective cohort studies
Dujits et al. also performed a cohort study in the
Netherlands (52), graded B due to a lack of power
calculation. They divided breastfeeding into five groups:
1) never (12.8%), 2) partial for B4 months, not thereafter
(29.2%), 3) partial 46 months (28.8%), 4) exclusive for
4 months, partial thereafter (25.7%), and 5) exclusive for
6 months (1.4%). (Partialbreastmilkformula and/
or solids.) Compared with never breastfed, those exclusively
breastfed 4 monthspartially thereafter had lower risk of
upper respiratory tract infection (URTI), LRTI, and GI
until 6 months (adjusted OR [95% CI] 0.65 [0.51, 0.83],
0.50 [0.32, 0.79], and 0.41 [0.26, 0.64], respectively) and
lower risk of LRTI between 7 and 12 months, adjusted
OR 0.46 (95% CI: 0.31, 0.69). Partial breastfeeding, even
for 6 months, did not result in significantly lower risks.
Fisk et al. (53), in a birth cohort study from South-
ampton, UK, compared gastrointestinal, respiratory, and
ear infections during 06 months and 612 months
between infants breastfed for seven different durations;
never breastfed,B1 months, 13 months, 4 months,
46 months, 711 months, 12 months. Twenty-five
percent of the infants were breastfed up to 6 months
and 10% for 12 months or longer. Except for ear
infections, an inverse dose-dependent relationship was
found between breastfeeding duration and morbidity.
Adjustment was done for several maternal and infant
factors, including smoking in pregnancy and age at intro-
duction of solid foods. Breastfeeding duration decreased
the risk of diarrhea (adjusted RR, 95% CI) for breast-
feeding6 months vs. never breastfeeding, 0.43 (0.30,
0.61). The authors also identified that each month of
additional breastfeeding decreased the risk of diarrhea.
Adjusted RR per month increase in breastfeeding was
0.88 (0.83, 0.92) at 06 months, p for trend B0.001, and
0.97 (0.95, 0.99) at 612 months, p for trend0.002.
They found similar significant results for vomiting,
wheezing, LRI, and general respiratory morbidity. There
was a non-significant association between breastfeeding
duration and prevalence of ear infection at 06 months
and at 612 months.
Ladomenou et al. (54) studied all infections as one
outcome. Prolonged exclusive breastfeeding was asso-
ciated with fewer infectious episodes (r(s)0.07, p
0.019) and fewer admissions to hospital for infection
(r(s)0.06, p0.037) in the first year of life. Partial
breastfeeding did not seem to have a protective effect.
As for AOM, infants exclusively breastfed for 6 months
presented with fewer infectious episodes than their par-
tially breastfed or non-breastfed peers and this protective
effect persisted after adjustment for potential confoun-
ders for AOM (OR 0.37 [95% CI: 0.13, 1.05]). A pro-
tective effect was also seen for acute respiratory infection
(ARI) (OR 0.58 [95% CI: 0.36, 0.92]), and thrush (OR
0.14 [95% CI: 0.02, 1.02]).
Rebhan et al. (40) showed in a prospective cohort
study that exclusive breastfeeding]6 months signifi-
cantly reduced the risk for GI episodes during months
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19 compared to those breastfed B4 months (includes
never breastfed). Adjusted odds ratio (OR) was 0.60 and
95% CI 0.440.82. However, some important confoun-
ders were not included, the follow-up period was only
9 months, and no power calculations were done.
Conclusion
Based on the present SLR, we conclude that the evidence
is convincing (grade 1) that breastfeeding protects infants
in industrialized countries against overall infections,
AOM, and gastrointestinal and respiratory tract infec-
tions. The magnitude of the effect varies depending on
the specific outcome and the exclusiveness of breast-
feeding. The definitions of breastfeeding varied in the
included studies and the methodology used to assess
breastfeeding was not always clear which is problematic.
A protective dose/duration-response effect on gastroin-
testinal or respiratory tract infections was found in the
SLRs of Dujits et al. (51) and Kramer (2), as well as in
the prospective studies by Fisk et al. (53) and Ladomenou
et al. (54).
Cancer
Supplementary Table 6 shows studies with outcome
childhood and adult cancers (details are provided in
Appendix 35). In total three papers were found in the
systematic review process; all were SLR/MAs. Of those,
one was graded A (22) and two were graded C (55, 56).
Neither of the C-graded SLR/MAs had used duplicate
study selection and data extraction in the SLR, most of
the included studies (80%) relied on long-term recall of
infant feeding, and moreover, in (55) only 8% examined
breastfeeding exclusivity and control response rates were
under 80% in over half. As there were so few studies with
cancer as the outcome the two studies graded C are
included below.
Ip et al. (22), graded A, was a systematic review of one
SLR and one meta-analysis (only including case-control
studies), both graded A by Ip et al. In addition, Ip et al.
also conducted a new meta-analysis of three case-control
studies. A total of 3,266 subjects with acute lymphocytic
leukemia (ALL) were included in the three studies. There
was an association between a history of breastfeeding of
at least 6 months and a reduction in the risk of both ALL
and acute myelogenous leukemia (AML). Breastfeeding
56 months vs. never breastfeeding: ALL OR 0.91 (95%
CI: 0.83, 1.00), breastfeeding 6 months vs. never
breastfeeding: ALL OR 0.80 (95% CI: 0.71, 0.91). Ip
et al. conclude that there is association between a history
of breastfeeding of at least 6 months duration and a
reduction in the risk of both ALL and AML.
Martin et al. (55) did an SLR, graded C, on childhood
cancers including 26 studies (mainly case-control) com-
paring ever or exclusive breastfeeding vs. never breastfed.
Having been breastfed was associated with lower risks for
acute lymphoblastic leukemia OR 0.81 (95% CI 0.84,
0.98), for Hodgkin’s disease OR 0.76 (95% CI 0.60, 0.97)
and for neuroblastoma OR 0.59 (95% CI 0.44, 0.78), with
little between-study heterogeneity. However, even if
causal, the authors state the public health importance
of these associations may be small.
Martin et al. (56) also did an SLR, graded C,
on adult cancers (breast, prostate, colorectal, gastric,
smoking-related) including 14 studies (mainly case-
control) also comparing ever or exclusive breastfeeding
vs. never breastfed. Their conclusion was that ever having
been breastfed was not associated with prostate, colo-
rectal, gastric, smoking-related cancers, nor overall breast
cancer risk RR 0.94 (95% CI: 0.85, 1.04). However,
breastfed women had a reduced risk of premenopausal
breast cancer RR 0.88 (95% CI: 0.79, 0.98) but not of
postmenopausal breast cancer RR 1.00 (95% CI: 0.86,
1.16).
Conclusion
Based on the present SLR, we judge that there is limited
but suggestive evidence (grade 3) for a risk reduction of
breastfeeding against childhood leukemia and possibly
other childhood cancers. The effect on childhood leuke-
mia seems larger with longer breastfeeding duration (6
months). However, as childhood cancers are relatively
rare, the public health importance of these associations
may be small. Research and evidence is too scarce and
weak to judge associations between breastfeeding and
cancers in adulthood.
Atopic disease
Supplementary Table 7 includes 13 studies relating
breastfeeding or introduction of solid foods to atopic
disease (details are provided in Appendix 35). These
include three SLRs/MAs and 10 prospective cohort
studies. All but one SLR (22) were graded B.
Breastfeeding/exclusive breastfeeding
SLR/Meta-analysis. Ip et al. (22) made a meta-analysis
of 18 prospective cohort studies with the outcome atopic
disease. When comparing infants exclusively breastfed
over 3 months vs. less than 3 months exclusively breastfed
children with a family history of atopy the OR was 0.58
(95% CI: 0.41, 0.92). When separating those with short
follow-up (B2 years) and those with longer ORs were
0.74 (95% CI: 0.61, 0.90) and 0.78 (95% CI: 0.62, 0.99),
respectively. For those without a family history of atopy
OR was 0.84 (95% CI: 0.59, 1.19).
Yang et al. (57) examined in a SLR/MA including 21
studies with 27 study populations, the association between
exclusive breastfeeding for at least 3 months and the
development of atopic dermatitis in childhood (17
years). There was no strong evidence of a protective effect
of exclusive breastfeeding for at least 3 months against
The 5th Nordic Nutrition Recommendations
Citation: Food & Nutrition Research 2013, 57: 20823 - http://dx.doi.org/10.3402/fnr.v57i0.20823 13
(page number not for citation purpose)
atopic dermatitis. As for the comparison group, exclusive
breastfeedingB3 months or breastfeeding combined with
formula feeding were defined as partial breastfeeding.
Fifteen studies compared with partial breastfeeding and 6
studies compared with infant formula, cow’s milk or soy
milk. In summary, for the effect of exclusive breastfeeding
on the risk of atopic dermatitis the OR was 0.89 (95% CI:
0.76, 1.04), and for study populations with atopic heredity
a pooled OR was 0.78 (95% CI: 0.58, 1.05). The authors
underline that due to substantial heterogeneity across
studies, the results should be interpreted with caution.
Prospective cohort studies. Bergmann et al. (58) report
on the association between total breastfeeding duration
and the prevalence of eczema during the first 7 years in a
German cohort. No consideration was given to other
foods and infants breastfedB1 week is combined with
those never breastfed. In total, 92% were breastfed at
maternity ward, but 2% received glucose solution and
49% formula in addition (36% cow’s milk formula and
13% hydrolyzed) which could have affected the results.
Breastfeeding was carried out longer if at least one parent
had eczema. Prevalence of eczema during first 7 years
increased with each additional month of breastfeeding
(OR 1.03 [95% CI: 1.001.06]), with a history of parental
eczema (OR 2.06 [95% CI: 1.38, 3.08]), and if other atopic
signs and symptoms appeared, especially specific sensiti-
zation (OR 1.53 [95% CI: 1.25, 1.88]), and asthma (OR
1.41 [95% CI: 1.07, 1.85]). Bergmann et al. conclude that
parental eczema is the major risk factor, but longer
duration of breastfeeding also increases the risk. Further-
more, although breastfeeding should be recommended
for all infants, it does not prevent eczema in children with
a genetic risk.
Elliott et al. (59) report on an analysis from a large
prospective cohort study (Avon Longitudinal Study of
Parents and Children [ALSPAC]) in England. They
studied duration of breastfeeding and exclusive breast-
feeding2 and atopy (skin-prick test) at 7 years. Duration
of any breastfeeding (never,B1 month, 13 months, 36
months, and 6 months) as well as exclusive breastfeed-
ing (never breastfed, exclusively breastfedB4 months,
exclusively breastfed]4 months) was compared with the
outcomes. They found no consistent evidence for either a
deleterious effect or a protective effect of breastfeeding on
later risk of allergic disease, even when their mothers were
asthmatic. Neither reverse causation nor low follow-up
appears to have biased the results.
Giwercman et al. (60) studied duration of exclusive
breastfeeding3 and eczema in the first 2 years of life in the
Copenhagen Prospective Study on Asthma in Childhood
(COPSAC) in a high-risk birth cohort (born to mothers
with a history of asthma). As a definition of exclusive
breastfeeding was not included, it is unclear what con-
stitutes duration of breastfeeding. It was found that
(exclusive) breastfeeding increased the risk of eczema
after adjustment for demographics, filaggrin variants,
parents’ eczema, and pets at home (n306; RR 2.09
[95% CI: 1.15, 3.80]; p0.016).
Three papers from the PROBIT-study focused on atopic
disease as the outcome; allergy and asthma at 6.5 years
evaluated through ISAAC questionnaire and skin-prick
tests (61), allergy symptoms during the first 6.5 years
evaluated through an ISAAC questionnaire (62), and
atopic symptoms evaluated through skin-prick tests (37).
The first paper reports that the experimental area had
no reduction in risks of allergic symptoms and diagnoses
or positive skin-prick tests (61). In fact, after exclusion
of six sites (three experimental and three control) with
suspiciously high rates of positive skin-prick tests, risks
were significantly increased in the experimental group
for four of the five antigens. The second paper reports
that maternal postnatal smoking was associated with
wheezing and hay fever symptoms, while the duration of
exclusive breastfeeding was not protective against any of
the studied outcomes (62). The risk factors for allergic
symptoms were similar in children with positive skin-prick
tests to those in the overall cohort. The third paper reports
that no significant differences in atopic outcomes were
found between the EBF3 and EBF6 groups (37).
Silvers et al. (63) studied the relationship between
breastfeeding (exclusive and any) and doctor-diagnosed
asthma, wheezing, inhaler use, and eczema at 15 months
of age at 15 months of age in the New Zealand Asthma
and Allergy cohort study.4 The median duration of exclu-
sive breastfeeding was 1.4 months (interquartile range
[IQR] 04) and of any breastfeeding was 9.0 months
(IQR 413). Breastfeeding was not associated with
eczema or atopy at 15 months.
Introduction of complementary foods
SLR/meta-analysis. Tarini et al. (64) conducted a SLR,
including 13 studies (n791,265) on early introduction
of solid foods (defined as before age 4 months) and allergy.
They concluded that early solid feeding may increase the
risk of eczema. However, there were little data support-
ing an association between early solid feeding and other
allergic conditions. The authors state that many of the
reviewed studies lacked a rigorous design and so were
susceptible to multiple biases. Five of nine studies found
a positive association between early solid feeding and
eczema, with persistence of the association for 10 years in
one study. Another study found an association between
early solid feeding and pollen allergy. No strong evidence
was found to support the association between early solid
2No definition of exclusive breastfeeding.
3No definition of exclusive breastfeeding. 4Other food was not taken into account.
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feeding and the development of persistent food allergy,
allergic rhinitis or animal dander allergy. In summary, the
authors conclude that the evidence linking early solid
feeding and allergic disease is inconsistent and conflicting.
Prospective cohort studies. Alm et al. (65) studied asso-
ciations between patterns of food introduction and the
risk of eczema. Food data were collected retrospectively
at 6 and 12 months. Introduction of fish at B9 months
of age decreased the risk, OR 0.76 (95% CI: 0.62, 0.94),
p0.009, but there was no effect of breastfeeding
duration. Maternal eczema increased the risk, OR 1.54
(95% CI: 1.30, 1.84), as did having a sibling with eczema
OR 1.87 (95% CI: 1.50, 2.33).
Snijders et al. (66) evaluated in a prospective birth
cohort study (KOALA) from the Netherlands age of first
introduction of cow’s milk products and other food
products and atopic manifestations in the first 2 years
of life. Breastfeeding duration was included as a con-
founder. They found that more delay in both introduction
of cow’s milk products and other food products was
associated with a higher risk for eczema at 2 years of age.
No associations were found between introduction of
cow’s milk products and atopic dermatitis (AD); however,
more delay in other food products was associated with a
higher risk for AD. A delayed introduction of other food
products was associated with an increased risk for atopic
sensitization. Exclusion of infants with early symptoms of
eczema (to avoid reverse causation) did not essentially
change the results.
Zutavern et al. (67) reported from a prospective study
in Germany (LISA birth cohort study) investigating
timing of solid food introduction and skin and allergic
symptoms at 6 years of age. They found that a delayed
introduction of solids (between 4 and 6 months or past
6 months) was not associated with decreased odds for
sensitization against food or inhalant allergens at 6 years
of age. On the contrary, food sensitization was more
frequent in children who were introduced to solids later.
They concluded that they found no evidence supporting a
delayed introduction of solids beyond 4 or 6 months for
the prevention of allergic rhinitis and food or inhalant
sensitization at the age of 6 years. For eczema, the results
were conflicting and a protective effect of a delayed
introduction of solids could not be excluded.
Reports. The American Association of Pediatrics (16)
states that there is evidence that breastfeeding for at least
4 months, compared with feeding formula made with
intact cow’s milk protein, prevents or delays the occur-
rence of AD and cow’s milk allergy in early childhood.
There is little evidence that delaying the timing of the
introduction of complementary foods beyond 46 months
prevents the occurrence of atopic disease. At present,
there are insufficient data to document a protective effect
of any dietary intervention beyond 46 months for the
development of atopic disease.
Swedish Pediatric Society (68) concludes that breast-
feeding has not been proven to decrease the risk of atopy
and allergies. Nor is there any evidence to indicate that it
is preferable to avoid giving the baby allergenic foods or
delay the introduction.
Conclusion. Based on the present SLR, we conclude
that the existing scientific evidence is very limited and no
conclusions (grade 4) can be drawn for any preventive
effects of breastfeeding on atopic diseases in children. Of
the two included SLR/MA studying the effect of exclusive
breastfeeding 3 months on the risk for atopic disease,
one found a protective effect (22), and the other found no
significant effect regardless of heredity (57). The third
SLR (64) looked at early introduction of solid food (B4
months) and concluded that early solid feeding may
increase the risk for eczema, but that little data support
an association between early solid feeding and other
allergic conditions. The results from the prospective
studies were similar. The prospective studies found no
protective effect of exclusive breastfeeding on the devel-
opment of atopic disease and the results from varying
ages of introduction of solids were conflicting. Long-
itudinal studies in cohorts of newborn infants could help
clarify the relationship of exclusively and/or duration of
breastfeeding, as well as introduction of solid foods, and
atopic diseases.
Asthma
Supplementary Table 8 shows 14 studies relating breast-
feeding or introduction of solid foods to asthma (details
are provided in Appendix 35). These include three SLRs/
MAs and 12 prospective cohort studies. All but one SLR
(22) were graded B.
Breastfeeding/exclusive breastfeeding
SLR/meta-analysis. Ip et al. (22) did a meta-analysis of
15 prospective cohort studies (12 included in a previous
meta-analysis graded A, and 3 newer studies all graded
B). Ip et al. conclude that in children without a family
history of asthma breastfeeding for more than 3 months
was associated with reduced risk of asthma compared
to not being breastfed (OR 0.73 [95% CI: 0.59, 0.92]).
This association was also found in subjectsB10 years of
age with a family history of asthma.
Kramer and Kakuma (2) conducted a SLR (including
controlled clinical trials and observational studies) on ex-
clusive breastfeeding (6 months vs. exclusive 34 months
with mixed breastfeeding) and wheezing or asthma. No
significant reduction in the risk of asthma has been
demonstrated. Risk of asthma at 56 years (pooled RR
was 0.91 [95% CI: 0.61, 1.36]) and risk of wheezing in the
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exclusively breastfed (6 months) group was RR 0.79 (95%
CI: 0.49, 1.28).
Prospective cohort studies. Elliott et al. (59) studied the
association between breastfeeding and the outcomes
wheeze at 3 and 7.5 years, asthma 7.5 years, and lung
function at 8 years. Duration of any breastfeeding (never,
B1 months, 13 months, 36 months and 6months) as
well as exclusive breastfeeding5 (never breastfeeding,
exclusively breastfedB4 months, exclusively breastfed
]4 weeks) was compared with the outcomes. Unfortu-
nately, both wheeze and asthma was self-reported and
there was no power calculation. No consistent evidence
for either a deleterious effect or a protective effect of
breastfeeding on later risk of allergic disease was found,
even when the mothers were asthmatic. The authors state
that neither reverse causation nor low follow-up appears
to have materially biased the results.
Fredriksson et al. (69) studied breastfeeding duration
and childhood asthma in a 6-year follow-up (children
714 years) population-based cohort study in Finland.
Chronic respiratory symptoms (persistent wheezing,
cough, phlegm) which could be indicators of future
asthma were studied as secondary outcomes. A U-shaped
relationship was found between breastfeeding duration
and prevalence of asthma, wheezing, and phlegm. The
lowest prevalence of asthma was found in children who
were breastfed for 46 months and of chronic respiratory
symptoms when the child was breastfed for 79 months.
The adjusted OR for asthma was 1.03 (95% CI: 1.00,
1.05) per 1-month increase in breastfeeding duration for
more than 6 months.
Giwercman et al. (60) reported from the Danish
COPSAC study in a high-risk birth cohort on duration
of exclusive breastfeeding6 and wheezy disorders during
the first 2 years of life. The risk of wheezy disorders was
reduced during the time the infant was (exclusively)
breastfed. They found that (exclusive) breastfeeding
reduced the risk of wheezy episodes in multivariate
analysis adjusted for maternal smoking and age at start
in day care (RR 0.67 [95% CI: 0.48, 0.96]; p0.021) and
of severe wheezy exacerbation (RR 0.16 [95% CI: 0.03,
1.01]; p0.051).
Karmaus et al. (70) studied the triad of maternal
prenatal smoking, any breastfeeding ]3 months, and
recurrent lower respiratory tract infection (RLRTI), and
their association on childhood asthma 010 years. Of the
three factors, RLRTI seemed to be the most important.
Breastfeeding ]3 months decreased the effects of both
RLRTI and smoking on asthma.
Kramer et al. (61) reported from the PROBIT-study
that there was no reduction in the risk of asthma at age
6.5 years when comparing the intervention with the
control areas. This does not support the view that
prolonged or exclusive breastfeeding has a protective
effect on asthma or allergy. A second paper (62) reports
that maternal postnatal smoking was associated with
wheezing and hay fever symptoms, while the duration of
exclusive breastfeeding was not protective against any of
the studied outcomes. The risk factors for allergic
symptoms were similar in children with positive skin-
prick tests to those in the overall cohort.
Kull et al. (71) studied recurrent wheeze, asthma, lung
function and, sensitization (specific IgE) at the ages 1, 2,
4, and 8 years in a birth cohort (BAMSE) in Sweden.
Comparisons were made between exclusive vs. partial
breast feeding, the durations of both were grouped into
three categories (0 to B2, 2 to B4, and ]4 months). The
majority, 80% were exclusively breastfed during the first
4 months, mean duration 5.1 months (SD 2.5 months).
At 8 years, exclusive breastfeeding for at least 4 months
reduced risk for asthma (adjusted OR 0.63 [95% CI: 0.50,
0.78]) compared with breastfeeding B4 months, espe-
cially when combined with sensitization; the risk of
allergic asthma was adjusted OR 0.59; 95% CI: 0.37,
0.93, while non-allergic asthma had an adjusted OR 1.18;
95% CI: 0.56, 2.48.
Midodzi et al. (72) studied several exposures (prenatal
problems, cesarean delivery, low birth weight, breastfeed-
ing, wheezing, allergy, infection, daycare) and the risk
for asthma 05 years. Breastfeeding was defined as never,
B3 months, and]3 months. Breastfeeding data were
collected with a retrospective questionnaire at recruit-
ment which occurred before 2 years. Breastfeeding was
not a major interest in the study but was reported to
decrease the incidence of asthma (breastfeeding3
months HR: 0.82 [95% CI: 0.69, 0.97]).
Scholtens et al. (73) measured specific immunoglobulin
E (IgE) to airborne allergen and bronchial responsiveness
in 8-year-old children who participated in the PIAMA
prospective birth cohort (Prevention and Incidence of
Asthma and Mite Allergy). Breastfeeding 16 weeks vs.
no breastfeeding was significantly associated with lower
asthma prevalence from 3 to 8 years of age (OR0.57
[95% CI: 0.41, 0.80]), this was also significant stratified
in children of non-allergic fathers (OR0.62 [95% CI:
0.40, 0.94]) and mothers OR 0.52 (95% CI: 0.34, 0.78)
and children with allergic fathers OR 0.51 (95% CI: 0.30,
0.86). It did not reach significance for children with
allergic mothers probably because of the low number of
children in the group.
Silvers et al. (63) studied the relation between breastfeed-
ing (exclusive and any) in relation to doctor-diagnosed
atopy at 15 months of age in the New Zealand Asthma and
Allergy cohort study. The median duration of exclusive
breastfeeding was 1.4 months (interquartile range [IQR]
04) and of any breastfeeding was 9.0 months (IQR 413).
5No definition of exclusive breastfeeding.
6No definition of exclusive breastfeeding.
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Breastfeeding significantly reduced the risk of adverse
respiratory outcomes at 15 months. Duration of exclusive
breastfeeding was a stronger determinant of respiratory
outcomes than the duration of any breastfeeding. After
adjustment for confounders, each month of exclusive
breastfeeding reduced risk of doctor-diagnosed asthma
by 20% (OR 0.80 [95% CI: 0.71, 0.90]), wheezing by 12%
(OR 0.88 [95% CI: 0.82, 0.94]) and inhaler use by 14%
(OR 0.86 [95% CI: 0.78, 0.93]). Each month of any breast-
feeding reduced the risk for these outcomes by 78%.
Children with the lowest risk for asthma were exclusively
breastfed for at least 3 months and continued breastfeeding
reduced the risk even more.7
Introduction of complementary foods
SLR/meta-analysis. The SLR by Tarini et al. (64) on
early introduction of solid foods (before age 4 months)
concluded that no strong evidence was found to support
the association between early solid feeding and the devel-
opment of asthma and/or wheezing. The SLR included
13 studies (n791,265). One case-control study found
a positive association with asthma, while three cohort
studies found no significant relationship with asthma by
4, 5, or 7 years. Furthermore, three cohort studies found
no significant association with episodes of wheezing,
while one found a positive association. In summary, the
authors conclude that the evidence linking early solid
feeding and allergic disease is inconsistent and conflicting.
Prospective cohort studies. Snijders et al. (66) reported
from the KOALA study in the Netherlands, a prospective
cohort study on age at first introduction of cow’s milk
products and other food products and atopic manifesta-
tions in the first 2 years of life. Breastfeeding duration
was included as a confounder. A delayed introduction of
other food products showed higher risk for recurrent
wheeze. They found that longer breastfeeding duration
(79 months) showed a reduced risk for recurrent wheeze,
and the risk for recurrent wheeze for breastfeeding9
months tended in the same direction.
Zutavern et al. (67) reported from a prospective study
in Germany (LISA birth cohort study) studying feeding
history at 6 months (solid food introduction) and skin
and allergic symptoms at 6 years. They found that a
delayed introduction of solids (between 4 and 6 months
or past 6 months) was not associated with decreased odds
for asthma at 6 years of age.
Reports. The American Association of Pediatrics (16)
states that there is evidence that breastfeeding for at least
4 months, compared with feeding formula made with
intact cow’s milk protein, prevents or delays the occur-
rence of wheezing in early childhood.
Swedish Pediatric Society (68) concludes that breast-
feeding gives some protection against infection-induced
airway symptoms of asthma type.
Complementary search. Brew et al. (74) conducted a sys-
tematic review and meta-analysis including birth cohort,
cross-sectional and case-control studies on breastfeeding
and wheezing illness in children aged over 5 years, graded
B (due to no statement about conflict of interest). Studies
that measured any breastfeeding or exclusive breastfeed-
ing for 3 or 4 months were included. Wheezing illnesses,
including asthma, were identified based on symptoms,
reported diagnosis or objective criteria. Meta-analysis of
23 studies that assessed any breastfeeding found that there
was no overall association between breastfeeding and
wheezing illness, however these studies were found to be
very heterogeneous. Similarly, meta-analysis of 13 studies
on exclusive breastfeeding for 3 or 4 months found no
association between exclusive breastfeeding and wheezing
illness. These studies were also found to be heterogeneous.
Subgroup analyses found that any breastfeeding slightly
lowers the odds of wheeze but slightly increases the odds
of asthma defined by specific criteria. The authors point
out that the difference in effects of breastfeeding accord-
ing to the nature of the wheezing illness highlights the
heterogeneous nature of the illness.
Brew et al. (75) graded B, analyzed data from two
cohorts, CAPS in Australia and BAMSE in Sweden,
which had reported different findings on the associa-
tion between breastfeeding and asthma. The definitions
for breastfeeding, asthma, and allergy were harmonized
and only participants with a family history of asthma
were included. Breastfeeding status, reported in infancy,
was defined as fully breastfed for 3 months or longer
and duration of any breastfeeding classified in months.
They found that breastfeeding reduced the risk of
asthma at 4, 5, and 8 years in children with a family
history of asthma. Stronger effect was seen in the Swedish
cohort.
Sonnenschein-van der Voort et al. (76) graded B,
studied duration and exclusiveness of breastfeeding and
asthma-related symptoms (including wheezing) in pre-
school children, as part of the prospective cohort study,
the Generation R Study in the Netherlands. Compared
with children breastfed for 6 months, those never
breastfed had overall increased risks of asthma-related
symptoms, and for wheezing the OR was 1.44 (95% CI:
1.24, 1.66). Similar associations were reported for ex-
clusive breastfeeding, and non-exclusively breastfed for
4 months had increased risk of wheezing (OR 1.21 [95%
CI: 1.09, 1.34]) compared with exclusively breastfed for
4 months. They concluded that shorter duration and non-
exclusiveness of breastfeeding were associated with in-
creased risk of asthma-related symptoms during the first
4 years of life, with the strongest effect estimates the first7Other food was not taken into account.
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2 years. Furthermore, that these associations seemed, at
least partly, to be explained by infectious, but not by
atopic mechanisms.
Conclusion. The studies included in the present SLR
on the association between breastfeeding and asthma
found contradictive results. One of the SLRs concluded
that breastfeeding for 3 months or more diminished the
risk of getting asthma (22), while the other found no
significant effect when comparing exclusive breastfeed-
ing for 34 months vs. 6 months (2). Similarly of 10
prospective studies, three found no effect (59, 61, 62), one
found a U-shaped relation with the lowest prevalence of
asthma with breastfeeding for 46 months (69), and the
remaining six prospective studies found diminished
wheeze or asthma risk associated with breastfeeding
(60, 63, 7073), of which one found a dose-response
relationship (63). For the studies testing association
between introduction of complementary foods and
asthma (64, 66, 67), none found a significant effect. In
conclusion, the present SLR found that the evidence
linking breastfeeding or introduction of solid foods to
asthma and wheeze is inconsistent, and the evidence is
limited and no conclusions can be drawn (grade 4).
The complementary search found three papers which
did not change our conclusion as they had differing
results. An SLR (74) found in subgroup analyses that any
breastfeeding slightly lowers the odds of wheeze but
slightly increases the odds of asthma defined by specific
criteria. However, in another study (75), data from two
cohort studies (one Australian and one Swedish) were
compared and found that breastfeeding reduced the risk
of asthma at 4, 5, and 8 years in children with a family
history of asthma. Stronger effect was seen in the Swedish
cohort. The third study (76) found that shorter duration
and non-exclusiveness of breastfeeding were associated
with increased risk of asthma-related symptoms during
the first 4 years of life, with the strongest effect estimates
the first 2 years.
IQ and neurological development
Supplementary Table 9 shows seven studies on breast-
feeding and development in childhood and includes one
SLR graded A (22), and six prospective cohort studies
graded B (details are provided in Appendix 35). One
additional prospective study was found through the
complementary search.
SLR/meta-analysis
Ip et al. (22) did an SLR including one SLR rated A, two
SLRs rated B, and eight new cohort studies (1A, 6B and
1C) and found little or no evidence for an association
between breastfeeding in infancy and cognitive perfor-
mance in childhood. Most studies did not differentiate
between exclusive and partial breastfeeding, and their
conclusions qualified with respect to the definitions used
for cognitive performance.
Prospective cohort studies
Jedrychowski et al. (77) studied the association between
exclusive breastfeeding of various durations and neuro-
development over a 7-year follow-up. The authors differ-
entiate between exclusive breastfeeding 53 months,
46 months, and 6 months. Complementary feeding
is defined as never breastfed or mixed fed the first
3 months. The authors write that children breastfed
exclusively for up to 3 months had intelligence quotients
(IQs) that were on average 2.1 points higher compared to
those mixed fed the first 3 months (95% CI: 0.24, 3.9);
children breastfed for 46 months scored higher by 2.6
points (95% CI: 0.87, 4.27); and the benefit for children
breastfed even longer (6 months) increased by 3.8
points (95% CI: 2.11, 5.45).8
In two papers from the PROBIT-study, Kramer et al.
focus on neurological development (37, 78). First com-
parisons of IQ at 6.5 years between the intervention area
and the control area were performed, n13,889 (78).
They conclude that the experimental area had higher
means on all of the Wechsler Abbreviated Scales of
Intelligence measures, with cluster-adjusted mean differ-
ences (95% CI) of 7.5 (0.8, 14.3) for verbal IQ; 2.9 (3.3,
9.1) for performance IQ; and 5.9 (1.0, 12.8) for full-
scale IQ. Academic ratings by teachers were significantly
higher in the experimental group for both reading and
writing. In the second paper (37), they compared 2,951
out of 3,483 total participants followed during the first
year. They found no significant differences between the
EBF3 and EBF6 groups on Wechsler Abbreviated Scales
of Intelligence measures, or teacher ratings on those that
had started school.
Oken et al. (79) studied developmental milestones at
18 months among 25,446 children. Breastfeeding expo-
sure (any) was divided intoB1 month, 23 months, 46
months, 79 months, and10 months. Children breastfed
23, 46, and6 months all showed higher motor devel-
opmental milestones and total developmental milestones
in comparison to those breastfedB1 month. Breastfed
6 months also showed higher social or cognitive
developmental milestones in comparison to breastfed
B1 month. Unfortunately, the study did not include
exclusive breastfeeding, there were no power calculations,
and study power and sample size was not considered
although the study included very many participants.
Whitehouse et al. (80) showed that the positive associa-
tions of breastfeeding on language ability found at 5 years
8Exclusive breastfeeding is defined in accordance with WHO, but it
is unclear whether it is actually used in practice, as 25% of infants
are reported to be exclusively breastfed >6 months, which seem
unlikely.
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of age in the Australian Raine Study, were still present at
the age of 10 years. Predominately breastfeeding was
presumed to occur up to introduction of milk other than
breast milk, and the definition did not preclude solids. A
doseresponse relationship was found between the dura-
tion of predominately breastfeeding and language ability
at 10 years, adjusted for several potential covariates,
including maternal education. Those predominately
breastfed for B4 months had higher language scores
than those never breastfed (regression coefficient [b]
2.71), while the effect was stronger for predominately
breastfed for 46 months (b3.83) and stronger still for
predominately breastfed for6 months (b4.04). The
magnitude of the dose-response association between
predominant breastfeeding and higher language scores at
10 years was comparable to the effect found at 5 years.
Zhou et al. (81) studied associations between breast-
feeding duration and IQ at 4 years of age in a prospective
cohort study in Australia. The participants were children
from a trial that investigated iron-supplementation in
pregnancy. Duration of breastfeeding was defined as
duration of any degree of breastfeeding (exclusive or
partial). Children who were breastfed for at least 6
months had higher IQ than those who were breastfed
for shorter duration. However, when adjusted for socio-
economic characteristics, the association between breast-
feeding duration and IQ of the children was no longer
significant. They found that the strongest predictor of IQ
at 4 years was the quality of the home environment.
Reports
A report from WHO (21) concludes that subjects who
were breastfed showed higher performance in intelligence
tests. All effects were statistically significant, but for some
outcomes their magnitude was relatively modest.
Complementary search
Oddy et al. (82), graded B, examined the relationship
between breastfeeding for 4 months or longer and child
development at age 1, 2, and 3 years in the Raine study.
Infant feeding data were collected at each age. Breastfeed-
ing (any breastfeeding) for 4 months or longer compared
with breastfeeding for less than 4 months was associated
with small but positive increases in psychomotor develop-
ment scores, like fine motor skills, adaptability, and
communication scores, from age 13 years. The authors
concluded that although the effect sizes were small,
breastfeeding for 4 months or longer were associated
with improved developmental outcomes for children aged
13 years after adjustment for multiple confounders.
Conclusion
In their SLR, Ip et al. (22) conclude that they saw little or
no evidence for a positive association between breastfeed-
ing and later cognitive performance of the child. However,
of the six later prospective cohort studies, four found
positive associations between breastfeeding and increased
IQ or developmental scores (77, 7981). Two of these even
found a stepwise increase with longer duration of breast-
feeding with highest IQ points or developmental scores
with breastfeeding longer than 6 months (77, 80). The
positive results from the PROBIT-study when comparing
the intervention and control areas (78) should also be seen
as quite strong evidence for positive associations, while
the non-results in their later paper (37) probably can be
explained by the fact that they compared children
exclusively breastfed for 3 or 6 months where differences
are likely to be smaller than in the other studies where
comparisons were made with children who were never
breastfed, mixed fed or breastfedB1 month. The last
study (81) found a positive association which was
attenuated and no longer significant after adjustment
for socioeconomic characteristics.
Based on the present SLR, we conclude that there is
probable evidence (grade 2) that breastfeeding is bene-
ficial for IQ and developmental scores of children, with
increasing benefit with increasing duration. One study
was found by the complementary search and it supported
the conclusion that breastfeeding is beneficial for neuro-
development (82).
Celiac disease
Supplementary Table 10 shows one SLR graded A with
outcome celiac disease and the association with breast-
feeding; Akobeng et al. (83). This was a systematic review
and meta-analysis of six observational case-control
studies of various size and age. The SLR included a total
of 1,131 cases and 3,493 controls (varying between 7 and
491, and between 73 and 1,949, respectively, in the
different studies). The ages varied between 2 and 15
years. The SLR only included studies based on histolo-
gically confirmed celiac disease, but the primary studies
compared different durations of breastfeeding and exact
timing of introduction and amount of gluten consumed
was not given. All included studies found a negative
association between breastfeeding and celiac disease. The
risk was especially reduced if the child was still breastfed
when gluten was introduced (pooled OR 0.48 [95% CI:
0.40, 0.59]). However, the authors make the observation
that it is not clear whether breastfeeding only delays the
onset of celiac disease or if it provides permanent
protection.
Reports
With regard to celiac disease, EFSA (17) state that
present available data support the belief that gluten
containing foods should be introduced not later than 6
months of age, preferably while still breastfeeding.
ESPGHAN (19) consider it prudent to introduce
gluten in small amount while the infant is still breastfed
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and to avoid both early (B4 months) and late (7
months) introduction of gluten.
In a joint statement, COT/SACN (50) state that they
considers the evidence strong for the protective effects of
introduction of gluten while breastfeeding is continued,
but do not consider the evidence sufficient to support the
precise statement about age at introduction of gluten
(except that introduction should not occur before 3
months).
Conclusion
Based on the present SLR, we judge it to be probable
evidence (grade 2) for breastfeeding as a protective factor
for celiac disease, if gluten is introduced in small amounts
while still breastfeeding, although it is unclear whether
the protection only delays the onset of celiac disease or if
it provides permanent protection. This conclusion is in
line with the reports from ESPGHAN (19), EFSA (17),
and COT/SACN (50). ESPGHAN (19) also considers it
prudent to introduce gluten in small amounts. However,
the evidence is limited and insufficient (grade 4) to
conclude which age is best for introduction of gluten.
Inflammatory bowel disease
Supplementary Table 11 shows one SLR graded A with
outcome inflammatory bowel disease (IBD) and the
association with breastfeeding; Klement et al. (84). This
SLR included 17 studies including 15 retrospective case-
control studies; 11 investigated both ulcerative colitis and
Crohn’s disease, three investigated ulcerative colitis alone,
and three investigated Crohn’s disease alone. Together a
total of 2,577 patients with ulcerative colitis and 3,551
control subjects and 3,190 patients with Crohn’s disease
and 4,026 control subjects were studied. Approximately
one quarter of the studies included adults only (18 year),
one quarter children (018 years), quarter a mix, and a
quarter was unknown. Seven of the included studies were
graded A. Breastfeeding had a statistically significant
protective role against ulcerative colitis and an even
greater role against Crohn’s disease. Pooled OR for
Crohn’s disease was 0.45 (95% CI: 0.26, 0.79) and for
ulcerative colitis 0.56 (95% CI: 0.38, 0.81) if only the
studies of good quality are included. When all studies
were included in the pooled estimate, the random-effects
model OR was 0.77 (95% CI: 0.61, 0.96) for ulcerative
colitis and 0.67 (95% CI: 0.52, 0.86) for Crohn’s disease.
Conclusion
Based on the present SLR, we judge there to be probable
evidence (grade 2) that breastfeeding provides protection
against IBD. The conclusion is based on the SLR above
which included 17 studies of which seven was graded A.
However, there is insufficient evidence to give exact
estimates of the risk reduction. Well-performed prospec-
tive studies with reliable, well-defined breastfeeding data
are needed.
Discussion
The overall aim of this systematic review was to evaluate
recent scientific data on the short- and long-term health
effects of breastfeeding (duration of any and exclusive
breastfeeding) on the child and introduction of foods
other than breast milk in order to assess the validity of
the current Nordic recommendations, NNR4 (12). A
second aim was to provide a background for the planned
update on the chapter on breastfeeding.
Five research questions were developed involving 12
different outcomes and studies related to these have been
presented in this review. A summary of the grading of
the evidence for the various outcomes is presented in
Supplementary Table 12. It should be emphasized that
the grading of evidence is only based on studies from year
2000 and onwards, searched for in June 2011, although
many earlier studies are part of the included SLRs/MAs.
We also excluded all papers on specific constituents of
breast milk, i.e. nutrients, biologically active substances,
and contaminants. A complementary search was per-
formed in January 2012, and the abstracts were evaluated
for full paper reading. Complementary papers were used
to evaluate the conclusion of the SLR, as supporting
or not.
Summary of results
We found the evidence convincing (grade 1) of a
protective dose/duration effect of breastfeeding against
overweight and obesity in childhood and adolescence, as
well as against overall infections, AOM, and gastrointes-
tinal and respiratory tract infections.
The evidence was probable (grade 2) that exclusive
breastfeeding for longer than 4 months is associated with
slower weight gain during the second half of the first year,
compared with shorter duration, but no negative health
effects are reported, rather that the slower growth in
infancy helps reducing risk of later overweight or obesity.
It is also of probable evidence that breastfeeding provides
a small but significant reductive effect on blood pressure
and on blood cholesterol later in life. Whether this has
any effect on the risk of CVD is, however, unclear. The
evidence is probable for beneficial effects of breastfeeding
on IQ and developmental scores of children. Breastfeed-
ing was also found to be a protective factor against IBD
and celiac disease; the latter if gluten is introduced while
still breastfeeding. There was also of probable evidence
that any breastfeeding is protective against T1DM and
T2DM, but the evidence for a larger protective effect of a
longer duration of breastfeeding is still limited even
though suggestive (grade 3).
There is also limited but suggestive evidence (grade 3)
for a risk reduction of breastfeeding against childhood
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leukemia and possibly other childhood cancers. The effect
seems larger on childhood leukemia with longer breast-
feeding duration (6 months). However, as childhood
cancers are relatively rare, the public health importance
of these associations may be small. Research and evi-
dence is too scarce and weak to judge associations be-
tween breastfeeding and cancers in adulthood (grade 4).
Longitudinal studies in cohorts of newborn infants
could help clarify the relationship of exclusive breastfeed-
ing and/or duration of any breastfeeding, as well as
introduction of solid foods, on the risk of atopic diseases,
asthma, wheezing, and eczema. The evidence was insuffi-
cient, and no conclusion could be drawn (grade 4) for
these associations nor about whether any specific age is
more advantageous for introduction of gluten to protect
against celiac disease. Other associations explored were
also inconclusive.
Discussion about specific outcomes
Growth, overweight, and obesity
The physiological explanations for the protective effect
of breast milk from development of overweight are not
totally clear and might partly rely on other foods intro-
duced as well. Selective reporting and/or publication bias
cannot be totally excluded in this area. Well-performed
prospective studies with longer duration of breastfeeding
as well as follow-up data are needed to evaluate breast-
feeding association with growth and/or body composition
later in life. Nordic collaboration with data from pro-
spective longitudinal infant cohorts is urgent as they likely
provide the best possibilities for improved studies on
longer duration of both exclusive and any breastfeeding
relevant to the Nordic populations.
Kramer et al. (38) found that smaller size (especially
weight for age) was strongly associated with increased
risks of subsequent weaning and of discontinuing exclu-
sive breastfeeding (adjusted OR varied between 1.2 and
1.6), especially between 2 and 6 months. This is proble-
matic as this may interfere with the possibility of drawing
appropriate conclusions, and specifically it can be ques-
tioned if the longer duration of exclusive breastfeeding
in e.g. (37) really is the cause of larger size at 6.5 years or a
confounder.
The first results from a RCT-study situated in a devel-
oped country (Iceland) have recently been published (85).
Infants taking part in the study were exclusively breastfed
and randomized to introduce complementary foods at
4 or 6 months while continuing to breastfeed. In total 119
infants were recruited and 100 (50/group) completed the
protocol. This first paper includes results from measure-
ments at 6 months on intake of breast milk and other
foods, anthropometry, and body composition. The study
showed similar energy intake, growth and body composi-
tion whether exclusive breastfeeding continued for 4 or 6
months.
Previous growth charts were based on infants fed
primarily infant formula which made them unsuitable
for infants fed according to the WHO recommendations
of exclusive breastfeeding for 6 months (86). Based on
large global samples of prospectively followed, breastfed
infants the new WHO child growth standards (45) bring
several advantages compared with the old growth refer-
ences. The opinion has been expressed that the new WHO
standards will both take the pressure of breastfeeding
women to give their babies formula or other food too
early, and decrease the risk of overfeeding as the new
chart gives a more realistic view of children growth (87).
Blood pressure, serum cholesterol, and CVD
The significant lower blood pressure (just over 1 mm Hg
systolic) seen in adults breastfed in infancy compared
with those not breastfed can be of less value to the
individual but important in a public health perspective.
One theoretical calculation from the mid-90s state that a
decrease of 2 mm Hg of the mean blood pressure in the
US population would result in 17% fewer people with
high blood pressure, 6% fewer people with CVD, and
15% fewer people with stroke/transient ischemic attacks
(88). Another study calculated that each increment of 20
mm Hg of systolic blood pressure and 10 mm Hg of
diastolic blood pressure doubles the risk for CVD (89).
How large effect a relatively small decrease in systolic
blood pressure, such as that associated with breastfeed-
ing, would have on CVD risk is unclear. No effects on
blood pressure in childhood were seen.
Breastfeeding was also found to result in a small
decrease of serum cholesterol in adults, while the effect
in childhood was unclear. In an SLR included in Ip et al.
(22), breastfed infants had higher cholesterol levels in
25 out of 26 studies but as that SLR was graded C no
conclusions could be drawn about the evidence level.
Whether the increased level in adults would have any
effect on CVD risk is unclear. In the present SLR, CVD
mortality was not included as an outcome. However, it was
studied in the SLR by Ip et al. (22), comprising an SLR/
MA (graded B) of four historical cohorts. Their conclu-
sion was that the data reviewed provided no evidence that
breastfeeding was related to all-cause or CVD mortality,
but that more studies were needed due to possible sources
of bias and limitations in the four included studies.
Diabetes mellitus, type 1 and 2 (T1DM and T2DM)
The evidence for any breastfeeding having a protec-
tive effect against T1DM and T2DM is probable (grade
2). The evidence for a stronger protective effect with
longer duration of breastfeeding is still limited but
suggestive (grade 3). However, it is unclear whether the
positive effects seen for breastfeeding depends on the
breast milk itself, on the avoidance of other foods given
to infants, or on other factors such as decreased number
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of infections for the breastfed child. More studies are
needed to clarify this.
Infections
The evidence that breastfeeding protects also infants in
industrialized countries against overall infections, AOM,
and gastrointestinal and respiratory tract infections is
convincing (grade 1). The magnitude of the effect varies
depending on the specific outcome and the exclusiveness
of breastfeeding. A protective dose/durationresponse
effect on gastrointestinal or respiratory tract infections
has been seen in several well-conducted studies.
Cancer
Two of the three SLRs found were graded C due to long-
term recall of breastfeeding data and no duplicate
study and data extraction. Based on three SLRs there
we judge the evidence to be limited but suggestive
(grade 3) for a risk reduction of breastfeeding against
childhood leukemia and possibly other childhood cancers.
The effect on childhood leukemia seems larger with longer
breastfeeding duration (6 months). However, as child-
hood cancers are relatively rare, the public health
importance of these associations may be small. Research
and evidence is too scarce and weak to judge associations
between breastfeeding and cancers in adulthood.
Atopy and asthma
The evidence is insufficient and no conclusion could be
drawn (grade 4) for the relationship of exclusive breast-
feeding and/or duration of any breastfeeding, as well as
introduction of solid foods, on the risk of atopic diseases,
asthma, wheezing, and eczema. Previous advice on
allergy prevention has included delayed introduction of
other foods, elimination of various foods as well as active
prevention by adding specific components either to the
pregnant/lactating woman or infant diet. These recom-
mendations have also changed over time.
It is well established that certain foods are more
allergenic than others (i.e. milk, eggs, fish, nuts, and
shellfish), but during the last decade there has been
debate about whether and to what degree breastfeeding
protects against atopic disease and asthma. The Swedish
Pediatric Society (68) conclude that breastfeeding gives
some protection against infection-induced airway symp-
toms of asthma type, but state that breastfeeding has not
been proven to decrease the risk of atopy and allergies.
Furthermore they state that there is no scientific evidence
that the risk of allergic disease in the infant is reduced if
the mother avoids certain foods during pregnancy or
breastfeeding. There is also no evidence to indicate that it
is preferable to avoid giving the baby allergenic foods or
to delay the introduction. Any positive effect of giving
different dietary supplements (n-3 fatty acids, pre-and
probiotics, or vitamins) remains to be shown. The same
applies to any advantage of the introduction of certain
food allergens before 6 months of age and/or during
breastfeeding. Introduction of other foods including how
timing, food choices, and amounts may affect the child’s
health in the short- and long-term is thus a relatively
unknown area, but several interesting studies have been
initiated.
Silvers et al. (63) found no association between
breastfeeding with eczema or atopy at 15 months, but a
significant dose-dependent effect on asthma, wheezing,
and inhaler use. They did not take other foods into
account.
Snijders et al. (66) reported from the KOALA study
in the Netherlands, a prospective cohort study on age at
first introduction of cow’s milk products and other food
products and atopic manifestations in the first 2 years of
life. A delayed introduction of other food products showed
higher risk for recurrent wheeze. They found that longer
breastfeeding duration (79 months) showed a reduced
risk for recurrent wheeze, and the risk for recurrent wheeze
for breastfeeding9 months tended in the same direction.
A question is if this, i.e. a higher risk related to delayed
introduction of other foods and at the same time a
protective effect of longer breastfeeding duration, should
be interpreted as a protective effect of introduction of
solids while breastfeeding continues, similar to the effect
seen for celiac disease. There are some ongoing studies that
might shed light on this in the future.
Even though the evidence was deemed to be inconclusive
and only grade 4 partly due to contradictive results, it is
however not far from grade 3. Future studies should make
sure to include all possible confounders, use good defini-
tions of feeding and doctors giving diagnosis; all important
factors to make it possible to compare studies.
IQ and neurological development
Not all studies find a beneficial effect of breastfeeding on
IQ and neurological development but no studies have
found detrimental effects or that formula feeding should
be advantageous in comparison. For instance, an earlier
meta-analysis by Anderson et al. (90) found a positive
effect while the SLR by Ip et al. (22) (where Anderson
et al. was included) concluded that they saw little or no
significant effects. However, as several strong cohort
studies published after the SLR by Ip et al. (22) show
positive effects of breastfeeding, and the few studies
showing no or non-significant effects can be explained,
we conclude that evidence is probable (grade 2) that
breastfeeding is beneficial for IQ and developmental
scores of children, with increasing benefit with increasing
duration.
Celiac disease
With regard to celiac disease we judge the evidence to be
probable (grade 2) for breastfeeding as a protective factor
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for celiac disease, but the evidence is insufficient (grade 4)
to conclude which age is best for introduction of gluten.
The most prudent way to introduce gluten is to introduce
it in small amounts while still breastfeeding. However, it
is unclear whether the protection only delays the onset
or if it provides permanent protection. A large screening
study has been conducted in Sweden (‘Exploring The
Iceberg of Celiacs in Sweden’ (ETICS), www.etics.se) to
shed light on this through screening at 12 years of age
of two birth cohorts born in 1993, during the height
of the Swedish ‘epidemic’ of clinical celiac disease in
childrenB2 years of age, and in 1997 after it had ended.
Recent data from this study show that children born in
1997, when a larger proportion were introduced to gluten
in small amounts while still breastfeeding, had a sig-
nificantly lower risk of having celiac disease compared
with those born in 1993 (prevalence ratio: 0.75 [95% CI:
0.60, 0.93]; p0.01) (91). This proves that the recom-
mendation regarding introduction of gluten is favorable
at least until 12 years of age.
Inflammatory bowel disease
We judge there to be probable evidence (grade 2) that
breastfeeding provides protection against IBD, but the
evidence is insufficient (grade 4) to give exact estimates of
the risk reduction. Well-performed prospective studies
with reliable, well-defined breastfeeding data are needed
to enable such estimates.
Difficulties with interpreting breastfeeding research
It is difficult to ascertain whether the positive effects seen
for breastfeeding depend on the breast milk itself and its
unique composition, on the avoidance of certain other
foods given to the infant, the action of breastfeeding or
on other associated factors. However, the nutrients and
biologically active substances in breast milk are numer-
ous, including vitamins, minerals, fatty acids, and various
immune factors and many of these have proven positive
effects on health.
Methodological problems with breastfeeding studies
include the following: long recall, poor definition of
exclusive breastfeeding, comparisons only between ever-
never breastfed, and no details about what infants eat
instead of or in addition to breast milk. In spite of the
quality criteria used in the present SLR, the definitions
of breastfeeding varied in the included studies and the
methodology used to assess breastfeeding was not always
clear which is problematic. As expected the strongest
evidence was found when comparing exclusive breastfeed-
ing with never breastfed.
In addition to the difficulties mentioned above there
are many other confounding factors when studying the
associations between infant feeding and health out-
comes. Since breastfeeding is influenced by many differ-
ent health-related factors, e.g. education, it can be
difficult to safely conclude that it is feeding itself that
explain positive health outcomes. The interpretation of
epidemiological studies with regard to infant feeding is
further complicated because the health outcome is
not only influenced by whether the child is breastfed or
not, what children are given instead of breast milk, and
the exposure this gives, but also, for example, the
facilitating effects breastfeeding have on motherinfant
bonding. The latter may for instance have effects on
development.
Well-performed prospective studies with well-defined
infant feeding methods are needed to evaluate breast-
feeding association with several of the outcomes. Nordic
collaboration with data from prospective longitudinal
infant cohorts would be valuable as there are pro-
bably good possibilities of methodologically strong
studies on longer duration of both exclusive and any
breastfeeding.
The importance of considering the aim of a study when
comparing results
Exclusive breastfeeding for about 6 months is recom-
mended by most official bodies, e.g. AAP (15, 16), EFSA
(17), ESPGHAN (18, 19), SACN (20), and WHO (13,
92). At the same time, EFSA (17) and ESPGHAN (19)
talks about introducing solid food between 4 and
6 months of age. This may seem contradictory, but
depends on different starting points for the scientific
reviews behind the recommendations. While the starting
point for WHO’s review (21) was to answer the question
of whether exclusive breastfeeding for 6 months is safe,
EFSA (17) wanted to answer the question whether there
are any disadvantages with starting to give complementary
foods in addition to breastfeeding in the age range of
46 months in Europe. Knowledge of this difference and
that the results do not conflict with each other is
important. If a mother continues to breastfeed after 6
months, there is no scientific evidence that the introduc-
tion of complementary foods between 4 and 6 months
would result in any health drawbacks for her child, but
there is also no evidence that it would bring any health
benefits.
A recent Cochrane review update by Kramer and
Kakuma (92) assessed the effects on child health, growth,
and development comparing exclusive breastfeeding for
6 months vs. exclusive breastfeeding for 34 months
followed by mixed breastfeeding through 6 months. They
share some, but not all, of the conclusions in the present
SLR on health effects of exclusive breastfeeding. With
regard to GI and allergic disease they draw the same
conclusions, i.e. a protective effect for infection and no
long-term effects for allergy. However, they also state
that exclusive breastfeeding for 6 months does not seem to
confer any long-term positive effects with regard
to obesity and cognitive ability compared to exclusive
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breastfeeding for 34 months. The reason for the dis-
crepancy is most likely that the aim of the new Cochrane-
update by Kramer and Kakuma (92) differs from the aim
of the present SLR. They only included studies comparing
infants who were exclusively breastfed for at least 6
months followed by mixed breastfeeding, with infants
introduced to liquid or solid foods between 3 and 6 months
of age followed by mixed breastfeeding until 6 months or
beyond. Thus their compared groups differed less than the
groups compared in most of the studies included in the
present SLR.
Concerns about vitamin D and iron
Breastfeeding has been questioned about whether it
gives enough vitamin D and iron to the breastfed infant.
With regard to vitamin D it has long been known that
infants and young children living in northern latitudes
need vitamin D supplements (especially the exclusively
breastfed infants) at least for some years. The experts on
vitamin D in the NNR5-project has focused their SLR on
what levels of supplementation should be recommended
to different age groups and thus, this is not part of the
present SLR.
There has also been concern that some infants will
experience negative effects on iron status if breastfed
exclusively for 6 months, and Kramer and Kakuma (92)
note that a reduced level of iron has been observed in
developing-country settings. The recent RCT-project from
Iceland mentioned above has also a paper on ferritin levels
accepted for publication (93). They report that at 6
months of age, the ferritin levels were lower in the group
exclusively breastfed for 6 months compared with infants
exclusively breastfed for 4 months and then receiving
small amounts of complementary food in addition to
breast milk until 6 months, but there was no indication or
evidence that the difference was of biological or clinical
importance.
Conclusions
Convincing and probable evidence was found for benefits
of breastfeeding on several outcomes. It is concluded
that the recommendation about exclusive breastfeeding
until 6 months of age from NNR2004 can stand un-
changed as well as the recommendation about breast milk
as part of the diet throughout the first year, and that
partial breastfeeding can be continued as long as it suits
mother and child. Considering the relatively low pro-
portion of infants in the Nordic countries following this
recommendation, strategies that protect, support and
promote exclusive breastfeeding for around the first 6
months of an infant’s life should be enhanced, and should
recognize the benefits for long-term health.
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